DaVita Inc. to Participate in UBS Global Healthcare Conference 2024
- DENVER , Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST (3:30 pm EST). To view the live webcast, visit the UBS page here and create a free registration.
- 11/08/2024
|
Why DaVita Stock Withered on Wednesday
- The company's profitability is going in the wrong direction for many investors.
- 10/30/2024
|
Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due
- This week marks a fire hose of earnings from several top Warren Buffett stock holdings. "Extraordinary business" Apple is on deck Thursday.
- 10/30/2024
|
DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up
- DVA's robust Dialysis patient service revenues drives its third-quarter performance.
- 10/30/2024
|
DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript
- DaVita Inc. (NYSE:DVA ) Q3 2024 Earnings Conference Call October 29, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Andrew Mok - Barclays AJ Rice - UBS Pito Chickering - Deutsche Bank Lisa Clive - Bernstein Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Justin Lake - Wolfe Research Operator Good evening. My name is Michelle and I will be your conference facilitator today.
- 10/29/2024
|
DaVita HealthCare (DVA) Q3 Earnings Miss Estimates
- DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, missing the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.85 per share a year ago.
- 10/29/2024
|
DaVita misses third-quarter profit estimates on higher costs
- DaVita reported third-quarter profit that missed Wall Street estimates on Tuesday, hurt by high patient care costs.
- 10/29/2024
|
DaVita Inc. 3rd Quarter 2024 Results
- DENVER , Oct. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2024. "We continue to provide quality care for our patients across the continuum of care, while delivering solid third quarter financial performance," said Javier Rodriguez, CEO of DaVita Inc. "And, in light of recent severe storms, I am grateful for the remarkable resilience of our patients and our frontline caregivers.
- 10/29/2024
|
6 Stocks Dominate Market's 'Best 6 Months' — Starting This Week
- If you had to choose the best time to invest in the S&P 500 — it's the six months starting in November.
- 10/29/2024
|
DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program
- The program aims to bring together a supportive network for people dealing with chronic health challenges for themselves and their loved ones DENVER , Oct. 28, 2024 /PRNewswire/ -- The DaVita Giving Foundation today announced an investment in the National Kidney Foundation (NKF)'s PEERS program, a program that provides social and emotional support for patients, care partners, and living donors through connections with mentors living through similar experiences. Prioritizing mental health in chronic disease care is essential, and mentorship can help provide people with support and comfort in a time when they might otherwise feel alone.
- 10/28/2024
|
DVA Q3 Estimates Unchanged Before Earnings: How to Play the Stock?
- Improvement in RPT is likely to have boosted DaVita's top line in the third quarter.
- 10/25/2024
|
DaVita Research Centers on Upstream CKD Management; Access & Equity during ASN's Kidney Week 2024
- DENVER and SAN DIEGO , Oct. 23, 2024 /PRNewswire/ -- DaVita Clinical Research (DCR), a leading innovator in kidney care research and wholly owned subsidiary of DaVita Inc., will present the results of five innovative research projects at the American Society of Nephrology (ASN)'s annual Kidney Week meeting, which is currently underway in San Diego, CA. With a focus on improving racial equity in transplantation and key measures of clinical quality such as hospitalizations, DCR works to tackle pressing issues in nephrology that affect diverse populations.
- 10/23/2024
|
DaVita HealthCare (DVA) Increases Despite Market Slip: Here's What You Need to Know
- DaVita HealthCare (DVA) concluded the recent trading session at $163.16, signifying a +1% move from its prior day's close.
- 10/22/2024
|
DaVita celebrates kidney care community achievements in year one of largest-ever value-based care program
- Nephrologists drive transformative outcomes through government's coordinated care program serving high-need patients DENVER , Oct. 22, 2024 /PRNewswire/ -- DaVita today announced performance year one clinical outcomes achieved in partnership with nearly 1,300 nephrologists across the U.S. through value-based care arrangements designed to enhance the lives of Medicare patients with kidney disease. As the broader health care community continues to explore value-based care arrangements to improve health outcomes in the U.S., DaVita commends the efforts from likeminded specialty care providers leading the movement.
- 10/22/2024
|
DaVita Appoints Jessica Hergenreter as Chief People Officer
- DENVER , Oct. 17, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced Jessica (Jess) Hergenreter as its new chief people officer (CPO). In this position, Hergenreter will oversee DaVita's People Services team, leading initiatives to engage and uplift DaVita's more than 70,000 teammates (employees) worldwide.
- 10/17/2024
|
DaVita HealthCare (DVA) Advances But Underperforms Market: Key Facts
- In the most recent trading session, DaVita HealthCare (DVA) closed at $164.82, indicating a +0.15% shift from the previous trading day.
- 10/16/2024
|
Can DaVita Stock Continue Its Bull Run After Doubling in a Year?
- DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.
- 10/16/2024
|
DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?
- DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 10/16/2024
|
Are Investors Undervaluing DaVita (DVA) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 10/14/2024
|
DaVita Opens its Doors to Anyone in Florida Needing Dialysis After Hurricane Milton
- TAMPA, Fla. , Oct. 11, 2024 /PRNewswire/ -- Following the widespread impact of Hurricane Milton, DaVita Kidney Care dialysis centers have opened their doors to anyone in Florida needing treatment, including those who normally treat at other providers.
- 10/11/2024
|
DaVita Inc. Schedules 3rd Quarter 2024 Investor Conference Call
- DENVER , Oct. 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, October 29, 2024, at 5:00 p.m. Eastern Time.
- 10/09/2024
|
DaVita Stock Gains 47.3% Year to Date: What's Behind the Rally?
- DVA's strong performance and growth strategies, including patient-centric care and international expansion, position it well for continued success despite potential risks.
- 10/09/2024
|
DaVita Prepares Thousands of Dialysis Patients for Hurricane Milton
- TAMPA , Oct. 8, 2024 /PRNewswire/ -- DaVita Kidney Care , a leading provider of kidney care services, has activated its emergency response plan in preparation for Hurricane Milton's landfall in Florida. DaVita's emergency response plans focus on proactively dialyzing thousands of patients ahead of the storm in more than 150 centers.
- 10/08/2024
|
Here's Why You Should Add DaVita Stock to Your Portfolio Now
- DVA's strength in its kidney care business raises optimism about the stock.
- 10/08/2024
|
Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 10/08/2024
|
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
- The Zacks Rank offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
- 10/03/2024
|
5 Stocks Trading Near 52-Week High With Room to Rise Further
- Investors target stocks that have been on a bullish run lately. Stocks like THC, SLVM, DVA, NCLH and IAG are seeing price strength, and the momentum is likely to continue.
- 10/02/2024
|
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
- DaVita HealthCare (DVA) closed the most recent trading day at $163.08, moving +0.51% from the previous trading session.
- 09/27/2024
|
Should Value Investors Buy DaVita (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/27/2024
|
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
- Here is how DaVita HealthCare (DVA) and Adagene Inc. Sponsored ADR (ADAG) have performed compared to their sector so far this year.
- 09/27/2024
|
DaVita Stock Rallies 17% in 3 Months: Is it Still Worth Buying?
- DVA stock has the potential to continue its uptrend on the back of better revenues per treatment as well as growth of the overall dialysis market.
- 09/27/2024
|
Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice
- Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 09/24/2024
|
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 09/24/2024
|
3 Stocks Warren Buffett Owns More Than 10% of Right Now
- In August, Warren Buffett's Berkshire Hathaway (NYSE: BRK-B) became the first non-tech U.S.
- 09/21/2024
|
Here's Why DaVita HealthCare (DVA) Fell More Than Broader Market
- DaVita HealthCare (DVA) closed the most recent trading day at $163.16, moving -0.65% from the previous trading session.
- 09/18/2024
|
DaVita HealthCare (DVA) Stock Falls Amid Market Uptick: What Investors Need to Know
- In the most recent trading session, DaVita HealthCare (DVA) closed at $164.22, indicating a -0.59% shift from the previous trading day.
- 09/17/2024
|
DaVita Accelerates Commitment to Community Health with Nationwide Tour
- Kidney care leader provides free health screenings and resources to create awareness around kidney disease and open discussion around health care access DENVER , Sept. 17, 2024 /PRNewswire/ -- DaVita (NYSE: DVA), a leading provider of kidney care services, today announced the launch of its 2024 nationwide community health tour beginning September 24.
- 09/17/2024
|
5 Stocks to Benefit From Relative Price Strength Trends
- LMB, UI, RCL, DVA and BOOT are five stocks with explosive relative price strength.
- 09/13/2024
|
3 Red Hot Stocks Flashing Buy Signals: DVA, ISRG, SN
- Stocks making new highs tend to make even higher highs, particularly when positive earnings estimate revisions hit the tape. And that's precisely what these three companies have seen.
- 09/13/2024
|
DaVita Inc. (DVA) Soars to 52-Week High, Time to Cash Out?
- DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 09/13/2024
|
DaVita Appoints David Maughan New Chief Operating Officer, Mike Staffieri Steps into Emeritus Role
- DENVER , Sept. 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that David Maughan will assume the role of chief operating officer.
- 09/13/2024
|
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 09/12/2024
|
Are Investors Undervaluing DaVita (DVA) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/11/2024
|
DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's What You Should Know
- DaVita HealthCare (DVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 09/10/2024
|
These Are the 2 Cheapest Stocks Warren Buffett Owns. Are They a Top Buy in September?
- Warren Buffett has obliterated the market's returns since becoming CEO of Berkshire Hathaway (NYSE:BRK-A)(NYSE:BRK-B) in the mid-1960s.
- 09/08/2024
|
DaVita HealthCare (DVA) Up 13% Since Last Earnings Report: Can It Continue?
- DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?
- 09/05/2024
|
DaVita Rallies 44% Year to Date: What's Driving the Stock?
- DVA's shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
- 09/02/2024
|
DaVita HealthCare (DVA) is a Great Momentum Stock: Should You Buy?
- Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 08/30/2024
|
Best Value Stocks to Buy for August 30th
- RCMT, AIZ and DVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 30, 2024.
- 08/30/2024
|
Drop Johnson & Johnson, Pick These Steady Eddie Stocks?
- If you are a Johnson & Johnson investor and have been enjoying the stock's steady dividends, it may be time to look elsewhere. As of this moment, we find DaVita - a healthcare company focused on kidney dialysis services - and Duke Energy - an electric and natural gas utility company based in North Carolina - as more attractive buys than Johnson & Johnson.
- 08/30/2024
|
3 Defensive Stocks Outperforming in a Choppy Market (PM, DVA, STWD)
- Broad markets, although continuing to trend higher, are showing signs of increasing volatility and uncertainty. While there has been a strong rally in stocks since the sharp correction earlier in the month, there is something peculiar happening under the surface.
- 08/28/2024
|
2 Must-Buy Medical Stocks With Strong Momentum
- Two medical stocks with strong momentum and a favorable Zacks Rank are: DVA, ILMN.
- 08/28/2024
|
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 08/27/2024
|
Best Momentum Stock to Buy for August 27th
- DVA, MRX and AIZ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 27, 2024.
- 08/27/2024
|
Is DaVita (DVA) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/26/2024
|
Warren Buffett portfolio: Billionaire's top 10 stock picks
- Warren Buffett, the famed ‘ Oracle of Omaha ,' allegedly made his first stock pick at age 11, all the way back in the early 1940s. In the following 80-odd years, he first became a millionaire, then a billionaire, and has perfected the art of getting rich slowly.
- 08/26/2024
|
4 Stocks Trading Near 52-Week High With More Upside Potential
- Investors target stocks that have lately been on a bull run. Stocks like PPC, THC, DVA and UHS are seeing price strength and have a high chance of carrying the momentum forward.
- 08/19/2024
|
DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?
- DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 08/15/2024
|
DaVita HealthCare (DVA) Is Up 0.56% in One Week: What You Should Know
- Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 08/14/2024
|
Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024
- There are better stocks to buy instead of Nvidia (NASDAQ: NVDA ). Although the chipmaker has been an absolute workhorse and promises to radically alter the artificial intelligence landscape, let's be real and admit NVDA stock is not cheap.
- 08/13/2024
|
DaVita Inc. Announces Pricing of $1.0 Billion Senior Notes Offering
- DENVER , Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering (the "offering") of $1.0 billion aggregate principal amount of its 6.875% senior notes due 2032 (the "2032 notes"). The 2032 notes were priced at 100.000% of their face amount to yield a 6.875% coupon.
- 08/08/2024
|
Is DaVita (DVA) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/08/2024
|
Are Medical Stocks Lagging DaVita (DVA) This Year?
- Here is how DaVita HealthCare (DVA) and Avadel (AVDL) have performed compared to their sector so far this year.
- 08/08/2024
|
DaVita Inc. Announces Offering of $1.0 Billion Senior Notes
- DENVER , Aug. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $1.0 billion aggregate principal amount of its senior notes due 2032 (the "2032 notes"), subject to market and other conditions. DaVita intends to use the net proceeds from the offering to (i) repay a portion of its outstanding Term Loan B-1 facility borrowings maturing in 2026 and a portion of its outstanding revolving credit facility borrowings, in each case, together with related accrued and unpaid interest thereon, (ii) pay any costs, fees and expenses in connection with the foregoing, and (iii) if any proceeds remain, for general corporate purposes, including, without limitation, for repurchases of its capital stock, working capital and capital expenditures.
- 08/08/2024
|
DaVita (DVA) Q2 Earnings & Revenues Top Estimates, Margins Up
- DaVita's (DVA) robust segmental revenues drive its second-quarter performance.
- 08/07/2024
|
DaVita HealthCare (DVA) Q2 Earnings and Revenues Surpass Estimates
- DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.47 per share. This compares to earnings of $2.08 per share a year ago.
- 08/06/2024
|
DaVita Inc. 2nd Quarter 2024 Results
- DENVER , Aug. 6, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2024. "On behalf of all the teammates who provide life-saving care to our patients, I am grateful for the opportunity to report another positive quarter for DaVita," said Javier Rodriguez, CEO of DaVita Inc. "We continue to enhance our clinical capabilities while optimizing our revenue operations and cost structure.
- 08/06/2024
|
The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data
- This marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earnings this week include: CSX, CAT, and VFC.
- 08/06/2024
|
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q2 Earnings
- Improvement in RPT and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the second quarter.
- 08/05/2024
|
4 Stocks to Watch From a Challenging Outpatient Home Health Industry
- Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised to gain.
- 07/31/2024
|
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights
- In the latest trading session, DaVita HealthCare (DVA) closed at $136.47, marking a -1.93% move from the previous day.
- 07/30/2024
|
2 Warren Buffett small-cap stocks to turn $100 into $1000 by 2025
- As the second half of 2024 unfolds, the stock market continues to offer various investment opportunities ranging from large to small-cap equities.
- 07/29/2024
|
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why
- The latest trading day saw DaVita HealthCare (DVA) settling at $139.96, representing a +1.46% change from its previous close.
- 07/22/2024
|
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call
- DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 6, 2024, at 5:00 p.m. Eastern Time.
- 07/18/2024
|
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts
- DaVita HealthCare (DVA) reachead $137.72 at the closing of the latest trading day, reflecting a +1.3% change compared to its last close.
- 07/16/2024
|
DaVita (DVA) Gains 29.8% YTD: What's Driving the Stock?
- DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
- 07/16/2024
|
Renal Denervation Devices Market Expected to Reach USD 387 Million by 2032 with a Remarkable 37.2% CAGR, According to Straits Research
- Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory surgery centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032 Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory surgery centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032
- 07/16/2024
|
US FTC probing DaVita, Fresenius Medical, Politico reports
- The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita and Fresenius Medical Care over allegations that the companies have been illegally thwarting smaller competitors, Politico reported on Saturday, citing three people familiar with the matter.
- 07/13/2024
|
Here's Why You Should Add DaVita (DVA) to Your Portfolio
- DaVita's (DVA) strength in its kidney care raises optimism about the stock.
- 07/12/2024
|
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 07/10/2024
|
DaVita HealthCare (DVA) Surpasses Market Returns: Some Facts Worth Knowing
- DaVita HealthCare (DVA) concluded the recent trading session at $137.92, signifying a +0.39% move from its prior day's close.
- 07/09/2024
|
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
- DaVita's (DVA) strength in its kidney care segment raises optimism about the stock.
- 07/04/2024
|
DaVita HealthCare (DVA) Stock Slides as Market Rises: Facts to Know Before You Trade
- In the latest trading session, DaVita HealthCare (DVA) closed at $142.16, marking a -0.53% move from the previous day.
- 06/26/2024
|
Are Medical Stocks Lagging DaVita (DVA) This Year?
- Here is how DaVita HealthCare (DVA) and Eledon Pharmaceuticals, Inc. (ELDN) have performed compared to their sector so far this year.
- 06/26/2024
|
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 06/24/2024
|
Should Value Investors Buy DaVita (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 06/24/2024
|
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
- DaVita HealthCare (DVA) closed the most recent trading day at $140.24, moving -1.39% from the previous trading session.
- 06/20/2024
|
Why DaVita HealthCare (DVA) is a Top Growth Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 06/17/2024
|
2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid
- One stock in Buffett's Berkshire Hathaway portfolio continues to grow its profits by leaps and bounds. Another ranks among his top performers in 2024 and is poised for growth, thanks to acquisitions.
- 06/15/2024
|
DaVita HealthCare (DVA) Stock Declines While Market Improves: Some Information for Investors
- DaVita HealthCare (DVA) reachead $142.16 at the closing of the latest trading day, reflecting a -0.37% change compared to its last close.
- 06/13/2024
|
3 PEG-Based Value Picks to Boost Your Portfolio Returns
- Invest in shares of Eldorado Gold (EGO), Sasol (SSL) and DaVita (DVA) that hold huge upside potential.
- 06/13/2024
|
DaVita (DVA) Gains 36% YTD: What's Driving the Stock Rally?
- DaVita's (DVA) shares have risen year to date on the back of strong performance and the acquisition of dialysis centers.
- 06/13/2024
|
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
- “Price is what you pay; value is what you get.” In 2008, Warren Buffett told Berkshire Hathaway (NYSE: BRK-A , BRK-B ) shareholders that buying good businesses when they're cheap was the quintessential way to amass wealth.
- 06/11/2024
|
DaVita, Nuwellis Extend Pilot Collaboration for Aquadex
- DaVita DVA recently extended the pilot phase of a previously announced supply and collaboration agreement with Nuwellis NUWE until Aug 31, 2024.At the conclusion of the pilot phase, DaVita may extend the supply agreement with Nuwellis for continued provision of both inpatient and outpatient ultrafiltration services for up to 10 years.
- 06/11/2024
|
5 Stocks to Gain as Service Side of the Economy Bounces Back
- With service sector activity rebounding in recent times, it's worth placing bets on stocks such as CareCloud (CCLD), DaVita (DVA), RadNet (RDNT), SkyWest (SKYW) and American Express (AXP).
- 06/11/2024
|
DaVita (DVA), Nuwellis Extend Pilot Collaboration for Aquadex
- DaVita (DVA) extends its pilot collaboration with Nuwellis to conduct additional testing of the Aquadex ultrafiltration treatment for adult patients suffering from congestive heart failure and related conditions.
- 06/10/2024
|
Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 06/10/2024
|
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
- Here is how DaVita HealthCare (DVA) and Twist Bioscience (TWST) have performed compared to their sector so far this year.
- 06/10/2024
|
These Warren Buffett stocks are crushing the S&P 500 in 2024
- Though investors of a different variety – such as Roaring Kitty of the GameStop (NYSE: GME) meme stock craze fame – have become increasingly popular in recent years, old-school investing legends have retained their prominent position among stock market aficionados.
- 06/10/2024
|
DaVita HealthCare (DVA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
- The latest trading day saw DaVita HealthCare (DVA) settling at $143.18, representing a -0.46% change from its previous close.
- 06/07/2024
|
Are Investors Undervaluing DaVita (DVA) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 06/07/2024
|
These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys?
- Nu Holdings stock skyrocketed in Q1 and remains Buffett's biggest winner this year. DaVita is expanding internationally.
- 06/07/2024
|
RADIANT LOGISTICS ACQUIRES OPERATIONS OF DVA ASSOCIATES, INC.
- Strengthens Company's presence in Portland, Oregon RENTON, Wash. , June 6, 2024 /PRNewswire/ -- Radiant Logistics, Inc. (NYSE American: RLGT), a leading provider of technology-enabled global transportation and value added logistics solutions, today announced it has acquired the operations of DVA Associates, Inc. ("DVA"), a Portland, Oregon based, privately held company that provides a full range of domestic and international transportation and logistics services across North America.
- 06/06/2024
|
Play Likely Earnings Beat With These 5 Top-Ranked Stocks
- Top-ranked stocks MGM Resorts International (MGM), Burlington Stores (BURL), Sterling Infrastructure Inc (STRL), Dropbox (DBX) and DaVita (DVA) are likely to beat on the bottom line in their upcoming releases.
- 06/05/2024
|
DaVita (DVA) Hits 52-Week High: What's Aiding the Stock?
- Investors are optimistic about DaVita's (DVA) strength in kidney care.
- 05/31/2024
|
DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?
- DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 05/30/2024
|
Ozempic cuts kidney-disease risks, research finds
- Novo Nordisk's diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, according to new research published Friday in the New England Journal of Medicine.
- 05/24/2024
|
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 05/23/2024
|
Is DaVita (DVA) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/22/2024
|
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?
- DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
- 05/21/2024
|
Here's Why You Should Hold Surmodics (SRDX) Stock for Now
- Surmodics, Inc. (SRDX Quick QuoteSRDX - Free Report) is well-poised for growth in the coming quarters, courtesy of its solid prospects in the thrombectomy business over the past few months. The optimism led by a solid second-quarter performance and consistent efforts to boost research and development (R&D) are expected to contribute further. Yet, concerns regarding regulatory headwinds and reliance on third parties persist.So far this year, this current Zacks Rank #3 (Hold) company has declined 4.8% against the industry’s 4.2% rise and the S&P 500’s 11.6% growth.The renowned medical device and in-vitro diagnostics technology provider has a market capitalization of $493.68 million. Surmodics projects 97.2% growth for fiscal 2025 and expects to maintain its strong performance. SRDX’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, the average earnings surprise being 165.93%. Image Source: Zacks Investment ResearchLet’s delve deeper.Consistent Efforts to Boost R&D: Surmodics’ solid efforts to improve its R&D stature have been a key growth driver, which raises our optimism. The company’s pipeline of vascular intervention medical device products under development and recently commercialized include primary platforms like DCBs, Mechanical thrombectomy devices and Radial access devices. In addition to these primary platforms, Surmodics’ device manufacturing operations include Specialty catheters.In the second quarter, Surmodics’ R&D expenses were 27.6% of total revenues. Medical Device R&D and other revenues increased 1.4% in the fiscal second quarter compared with the prior-year quarter, driven by increased volume of performance coating services.Thrombectomy Prospects Bright: Surmodics’ aim to leverage its proprietary Pounce thrombectomy platform technology to develop products raises our optimism. The company announced the completion of limited market evaluation and commercial launch of two new mechanical thrombectomy systems for the peripheral venous and arterial vasculatures, the Pounce Venous Thrombectomy System and the Pounce LP (Low Profile) Thrombectomy System during the fiscal second quarter.In January, Surmodics announced the successful early clinical use of the Pounce LP Thrombectomy System. Strong Q2 Results: Surmodics registered a solid uptick in the overall top and bottom lines in the second quarter. Product sales growth in the Medical Device segment was driven primarily by the fulfillment of the initial stocking order for the SurVeil DCB from Abbott and continued sales growth from the Pounce thrombectomy device platform.DownsidesRegulatory Headwinds: Surmodics’ facilities and procedures are subject to periodic inspections by the FDA to determine compliance with the latter’s requirements. On account of non-compliance with applicable laws or regulations, the FDA could ban such medical devices. Any adverse regulatory action can potentially hurt Surmodics' business practices and operations.Reliance on Third Parties: A principal element of Surmodics’ business strategy is to enter into licensing arrangements with medical devices and other companies that manufacture products incorporating its technologies. The company’s revenues from such arrangements depend upon its ability or its licensees’ ability to successfully develop, obtain regulatory approval for manufacture (if applicable), and market and sell products incorporating Surmodics’ technologies. Any failure to meet these requirements could have an adverse effect on its business.Estimate TrendSurmodics is witnessing a positive estimate revision trend for fiscal 2024. In the past 30 days, the Zacks Consensus Estimate for its loss per share has narrowed from 90 cents to 72 cents.The consensus estimate for the company’s third-quarter fiscal revenues is pegged at $30.3 million, suggesting a 42.2% decline from the year-ago reported number. Loss for the period is estimated to widen 157.7% year over year to 30 cents per share.Surmodics, Inc. Price Surmodics, Inc. price | Surmodics, Inc. QuoteKey PicksSome better-ranked stocks in the broader medical space are DaVita Inc. (DVA Quick QuoteDVA - Free Report) , Align Technology (ALGN Quick QuoteALGN - Free Report) and Medpace (MEDP Quick QuoteMEDP - Free Report) .DaVita, sporting a Zacks Rank #1 (Strong Buy) at present, has an estimated long-term growth rate of 13.6%. Its earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 29.4%. DaVita’s shares have risen 33.4% compared with the industry’s 11.2% growth year to date.Medpace, sporting a Zacks Rank of 1 at present, has an estimated long-term growth rate of 17.9%. Its earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 12.8%.Medpace’s shares have risen 28.3% year to date compared with the industry’s 4.9% growth.Align Technology, carrying a Zacks Rank #2 (Buy) at present, has an estimated long-term growth rate of 6.9%. Its earnings surpassed estimates in three of the trailing four quarters and missed the same in one quarter, delivering an average surprise of 5.9%.ALGN’s shares have declined 0.9% year to date against the industry’s 2.8% growth. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>
- 05/20/2024
|
DaVita Celebrates Corporate Citizenship Achievements with Release of 2023 Community Care Report
- DENVER , May 14, 2024 /PRNewswire/ -- Today, DaVita (NYSE: DVA) published its 2023 Community Care Report, underscoring its dedication to corporate social responsibility and commitment to setting a new standard for health care services. DaVita's annual Community Care Report examines progress toward its 2025 Environmental, Social, and Governance (ESG) goals to help improve the lives of patients and support the health of communities globally.
- 05/14/2024
|
DaVita Appoints New Chief Information Officer
- Madhu Narasimhan named to leadership role to accelerate technology-based innovations at DaVita DENVER , May 13, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that Madhu Narasimhan will assume the role of chief information officer (CIO), effective June 3, 2024. In this leadership position, Narasimhan will be responsible for accelerating the implementation of DaVita's industry-leading health technology platforms.
- 05/13/2024
|
5 Stocks Trading Near 52-Week High With More Upside Potential
- Investors target stocks that have lately been on a bull run. Stocks like HAS, EAT, DVA, LDOS and ALL are seeing price strength and have a high chance of carrying the momentum forward.
- 05/10/2024
|
4 Must-Buy Momentum Stocks Banking on the Driehaus Strategy
- DaVita (DVA), Minerals Technologies (MTX), Alphabet (GOOGL) and Garmin (GRMN) have been selected as the momentum picks for the day using the Driehaus strategy.
- 05/10/2024
|
DaVita Inc. to Participate in the BofA Securities 2024 Health Care Conference
- DENVER , May 9, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at BofA Securities 2024 Health Care Conference on Tuesday, May 14th, 2024 at 5:00 pm Pacific Daylight Time. To view the live webcast, visit the BofA page and create a free registration.
- 05/09/2024
|
Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice
- Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 05/09/2024
|
DaVita Honors 54 Nephrology Nurses with DAISY Awards
- Award celebrates excellence in nursing, underscoring the kidney care provider's commitment to recognizing the indelible impact of clinicians on outstanding patient care DENVER , May 9, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced that 54 of its nephrology nurses were honored with the DAISY Award® for Extraordinary Nurses during National Nurses Week. The award is part of The DAISY Foundation's mission to recognize nurses who provide outstanding, compassionate care in more than 6,500 health care facilities nationwide.
- 05/09/2024
|
4 Stocks to Buy in a Thriving Outpatient Home Health Industry
- Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and PNTG are well-poised to gain.
- 05/08/2024
|
Are Medical Stocks Lagging DaVita (DVA) This Year?
- Here is how DaVita HealthCare (DVA) and Alcon (ALC) have performed compared to their sector so far this year.
- 05/07/2024
|
Top 5 Outpatient and Home Healthcare Stocks for Solid Returns
- We have narrowed our search to outpatient and home healthcare stocks that have strong growth potential for 2024. These are: DVA, ADUS, OPCH, EHC, PNTG.
- 05/07/2024
|
DaVita HealthCare (DVA) is a Top-Ranked Value Stock: Should You Buy?
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 05/06/2024
|
Is DaVita (DVA) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/06/2024
|
DaVita Inc. (DVA) Hits Fresh High: Is There Still Room to Run?
- DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 05/06/2024
|
New Strong Buy Stocks for May 6th
- ROOT, SMCI, PPC, DFH and DVA have been added to the Zacks Rank #1 (Strong Buy) List on May 6, 2024.
- 05/06/2024
|
Best Value Stocks to Buy for May 6th
- DFH, DVA and BDC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 6, 2024.
- 05/06/2024
|
DaVita (DVA) Q1 Earnings & Revenues Top Estimates, Margins Up
- DaVita's (DVA) robust segmental revenues drive its first-quarter performance.
- 05/03/2024
|
DaVita Inc. (DVA) Q1 2024 Earnings Call Transcript
- DaVita Inc. (NYSE:DVA ) Q1 2024 Earnings Conference Call May 2, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Andrew Mok - Barclays Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Dean Rosales - Wolfe Research Gary Taylor - Cowen A.J. Rice - UBS Lisa Clive - Bernstein Operator Good evening.
- 05/02/2024
|
DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates
- DaVita HealthCare (DVA) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $1.96 per share. This compares to earnings of $1.58 per share a year ago.
- 05/02/2024
|
DaVita gains after upbeat quarterly profit prompts annual forecast raise
- DaVita raised its annual profit forecast on Thursday banking on strong demand for its kidney dialysis services, sending its shares up 3.7% in trading after the bell.
- 05/02/2024
|
DaVita Inc. 1st Quarter 2024 Results
- DENVER , May 2, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2024. "Through the first quarter, we continued building on the momentum generated through 2023, demonstrating operational discipline while continuing to find opportunities to invest, innovate and most importantly deliver clinical excellence," said Javier Rodriguez, CEO of DaVita Inc. Financial and operating highlights for the quarter ended March 31, 2024: Consolidated revenues were $3.071 billion.
- 05/02/2024
|
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q1 Earnings
- Improvement in revenue per treatment and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the first quarter.
- 05/01/2024
|
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
- Finding firms with strong growth potential is essential for healthcare investors looking for large profits. Three exceptional firms have surfaced as strong healthcare stocks.
- 05/01/2024
|
Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now?
- Mitsubishi is a stock Buffett plans to own "indefinitely" and is his biggest winner year to date. Nu Holdings continues to grow by leaps and bounds in Latin America.
- 04/27/2024
|
Is Trending Stock DaVita Inc. (DVA) a Buy Now?
- Recently, Zacks.com users have been paying close attention to DaVita HealthCare (DVA). This makes it worthwhile to examine what the stock has in store.
- 04/23/2024
|
DaVita HealthCare (DVA) Advances While Market Declines: Some Information for Investors
- DaVita HealthCare (DVA) closed at $127.82 in the latest trading session, marking a +1.36% move from the prior day.
- 04/19/2024
|
DaVita HealthCare (DVA) Registers a Bigger Fall Than the Market: Important Facts to Note
- The latest trading day saw DaVita HealthCare (DVA) settling at $126.11, representing a -1.2% change from its previous close.
- 04/18/2024
|
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 04/18/2024
|
DaVita Inc. Schedules 1st Quarter 2024 Investor Conference Call
- DENVER , April 17, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 2, 2024, at 5:00 p.m. Eastern Time.
- 04/17/2024
|
Market Jitters: 2 Top Ranked Stocks for Defensive Positioning
- Just this morning, the CPI data reported a notable and surprise increase in the rate of inflation. Although disinflationary pressure have been strong since early 2023, it seems those forces have reversed, and policymakers may have to deal with the changing expectations.
- 04/10/2024
|
Here's Why You Should Add DaVita (DVA) to Your Portfolio
- DaVita's (DVA) strength in its kidney care raises optimism about the stock.
- 04/10/2024
|
Should Value Investors Buy DaVita (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 04/10/2024
|
Is Most-Watched Stock DaVita Inc. (DVA) Worth Betting on Now?
- Zacks.com users have recently been watching DaVita HealthCare (DVA) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
- 04/10/2024
|
Why the Market Dipped But DaVita HealthCare (DVA) Gained Today
- In the closing of the recent trading day, DaVita HealthCare (DVA) stood at $133.73, denoting a +0.09% change from the preceding trading day.
- 04/08/2024
|
Diagnosing the Economy Ahead of World Health Day: 6 Picks
- Similar to the six vital nutrients required for good health, we have examined the six pillars that support the economy and zeroed in on stocks that have a Zacks Rank #1 (Strong Buy) or 2 (Buy) and a higher market cap in their respective sectors.
- 04/05/2024
|
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 04/02/2024
|
Are Investors Undervaluing DaVita (DVA) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/25/2024
|
DaVita HealthCare (DVA) Is Up 1.09% in One Week: What You Should Know
- Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 03/21/2024
|
DaVita HealthCare (DVA) Is Up 1.09% in One Week: What You Should Know
- Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 03/21/2024
|
4 Stocks Trading Near 52-Week High That Can Climb Further
- Investors target stocks that have been on a bullish run lately. Stocks like HST, EAT, DVA and PPC that are seeing price strength have a high chance of carrying the momentum forward.
- 03/21/2024
|
3 No-Brainer Warren Buffett Stocks to Buy Right Now
- Coca-Cola has a dividend yield that's more than double that of the S&P 500. Moody's has a large market share of the credit ratings segment.
- 03/19/2024
|
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 03/15/2024
|
DaVita HealthCare (DVA) Up 12% Since Last Earnings Report: Can It Continue?
- DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?
- 03/14/2024
|
New Strong Buy Stocks for March 14th
- IMMR, NVR, SKWD, DVA and APAM have been added to the Zacks Rank #1 (Strong Buy) List on March 14, 2024.
- 03/14/2024
|
Best Value Stocks to Buy for March 14th
- IMXI, SKWD and DVA made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 14, 2024.
- 03/14/2024
|
DaVita Inc. to Participate in the Barclays Global Healthcare Conference 2024
- DENVER , March 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at Barclays Global Healthcare Conference 2024 on Wednesday, March 13, 2024, at 8:00 a.m. EDT. To view the live webcast, visit the Barclays page and create a free registration.
- 03/08/2024
|
Should Value Investors Buy DaVita (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 03/08/2024
|
Davita (DVA) Shares Gain This Week: Will the Rally Continue?
- DaVita (DVA) stock soars as Novo Nordisk's study shows that although weight-loss drug reduces death risk for chronic kidney disease patients, demand for dialysis services will remain.
- 03/08/2024
|
Market Leaders Rolling Over: Time to Rotate into Defensive Stocks?
- Although the stock market has rallied almost non-stop since the start of the year, cracks are beginning to form that indicate a correction may be nearing. Not that I am sounding the alarm for some severe bear market, but rather I would not be surprised to see a garden variety pullback of 5-10% over the next month or so.
- 03/07/2024
|
DaVita (DVA) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about DaVita's (DVA) strength in its kidney care.
- 03/06/2024
|
DaVita (DVA) Expands Operational Footprint Via New Agreement
- DaVita's (DVA) latest agreement is expected to serve a wider patient pool across Latin America.
- 03/06/2024
|
DaVita Inc. (DVA) Hit a 52 Week High, Can the Run Continue?
- DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 03/06/2024
|
5 Best PEG-Based GARP Stocks for Investors
- Here are the five stocks that qualify our screening criteria ??? RCL, DVA, F, FIS and ITRI.
- 03/01/2024
|
Are You Looking for a Top Momentum Pick? Why DaVita HealthCare (DVA) is a Great Choice
- Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 02/23/2024
|
Here's Why DaVita HealthCare (DVA) is a Strong Momentum Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 02/22/2024
|
Markets Appear Vulnerable: Hideout in these 3 Top Ranked Defensive Stocks
- The stock market has moved aggressively higher since the start of the year with the S&P 500 gaining 4.6% YTD and the Nasdaq 100 5.2%. While there is nothing inherently wrong with the market showing such strength, there are a few concerning developments brewing that may lead to at least a minor correction in the coming weeks.
- 02/21/2024
|
Earnings Estimates Moving Higher for DaVita HealthCare (DVA): Time to Buy?
- DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 02/21/2024
|
Should Value Investors Buy DaVita (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/21/2024
|
3 Top-Rated Stocks to Buy After Comfortably Surpassing Earnings Expectations
- Investors are always looking for stocks of companies that illustrate business operations are stronger than anticipated and here are three to consider.
- 02/15/2024
|
4 Stocks to Watch in a Resilient Outpatient Home Health Industry
- The rising dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry despite the macroeconomic challenges. DVA, EHC, OPCH and ADUS are well-poised to gain.
- 02/15/2024
|
Why DaVita Stock Popped Today
- DaVita beat revenue and earnings estimates for its fourth quarter. The company has proven resilient in the wake of the COVID-19 pandemic.
- 02/14/2024
|
DaVita Stock Is Having Its Best Day in Years. Volumes Are Improving After Covid-19.
- Dialysis provider DaVita reported fourth-quarter financials above Wall Street's consensus.
- 02/14/2024
|
DaVita (DVA) Q4 Earnings & Revenues Top Estimates, Margins Up
- DaVita's (DVA) robust segmental revenues drive its fourth-quarter performance.
- 02/14/2024
|
DaVita Inc. (DVA) Q4 2023 Earnings Call Transcript
- DaVita Inc. (DVA) Q4 2023 Earnings Call Transcript
- 02/13/2024
|
DaVita HealthCare (DVA) Q4 Earnings and Revenues Top Estimates
- DaVita HealthCare (DVA) came out with quarterly earnings of $1.87 per share, beating the Zacks Consensus Estimate of $1.53 per share. This compares to earnings of $1.11 per share a year ago.
- 02/13/2024
|
DaVita gains after co says expects strong 2024 profit
- DaVita forecast 2024 profit above Wall Street estimates on Tuesday on anticipated strong demand for its kidney dialysis services, sending its shares up 4.8% after the bell.
- 02/13/2024
|
Time to Buy These High Growth Stocks as Earnings Approach
- This week's earnings lineup will be highlighted by several growth stocks with none standing out more than Airbnb (ABNB) and DaVita (DVA).
- 02/12/2024
|
DaVita (DVA) to Report Q4 Earnings: What's in the Offing?
- Improvement in revenue per treatment and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the fourth quarter.
- 02/09/2024
|
Are Investors Undervaluing DaVita (DVA) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 02/01/2024
|
Strong January is a Good Omen for Wall Street: 5 Growth Picks
- As the S&P 500 is poised to finish January in the green and continue its winning streak, investing in some growth stocks such as Arista Networks (ANET), Netflix (NFLX) and DaVita (DVA) seems judicious.
- 01/31/2024
|
DaVita Inc. Schedules 4th Quarter 2023 Investor Conference Call
- DENVER , Jan. 23, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Tuesday, February 13, 2024, at 5:00 p.m. Eastern Time.
- 01/23/2024
|
Why DaVita HealthCare (DVA) is a Top Momentum Stock for the Long-Term
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 01/22/2024
|
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 01/19/2024
|
Should Value Investors Buy DaVita (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 01/16/2024
|
Don't Overlook These Top Value Stocks in January It's Time to Buy
- With "A" Zacks Style Scores grades for Value here are three top-rated stocks with fundamental valuations that shouldn't be overlooked at the moment.
- 01/12/2024
|
5 Mid-Cap Stocks to Buy in a Volatile January
- We have narrowed our search to five mid-caps that have strong potential for 2024. These are: DVA, MNDY, GTLB, LNW, SRPT.
- 01/10/2024
|
How to Find Great Momentum Stocks to Buy in 2024
- The screen we explore today aims to find Zacks Rank #1 (Strong Buy) stocks that boast strong upward price momentum to help investors buy potential winners in January and throughout 2024.
- 01/09/2024
|
Best Growth Stocks to Buy for January 9th
- EG, BROS and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 9, 2024.
- 01/09/2024
|
3 Stocks Set to Soar 68% to 200% Higher
- After hitting new all-time highs in 2023, the S&P 500 is off to a slower start this year. The broad-based index is down 1.5% in the first week of trading.
- 01/08/2024
|
Best Growth Stocks to Buy for January 5th
- BROS, DVA and EVBG made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 5, 2024.
- 01/05/2024
|
Best Growth Stocks to Buy for January 3rd
- BROS, DVA and EVBG made it to the Zacks Rank #1 (Strong Buy) growth stocks list on January 3, 2024.
- 01/03/2024
|
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
- Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
- 12/29/2023
|
5 Stocks Trading Near 52-Week High That Can Climb Further
- Investors target stocks that have been on a bullish run lately. Stocks like DVA, BECN, CASY, FLR and CWCO that are seeing price strength have a high chance of carrying the momentum forward.
- 12/29/2023
|
DVA vs. CHE: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either DaVita HealthCare (DVA) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
- 12/27/2023
|
3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2024
- Here are some dirt-cheap MedTech value stocks - DVA, GEHC, HOLX - which are expected to provide long-term gains.
- 12/27/2023
|
Three Reasons to Add DaVita (DVA) Stock to Your Portfolio
- DaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock.
- 12/26/2023
|
Should Value Investors Buy DaVita (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/25/2023
|
5 S&P 500 Winners of 2023 That Are Must Buys for 2024
- We have narrowed our search to five S&P 500 stocks. These are: RCL, LYV, AIZ, DVA, AMZN.
- 12/22/2023
|
Best Growth Stocks to Buy for December 22nd
- DVA, LZ and MPTI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 22, 2023.
- 12/22/2023
|
Santa Claus Rally Sets In: 4 Stocks From Top Sectors to Play
- Tap top-ranked Otter Tail (OTTR), Rollins (ROL), DaVita (DVA) and NetEase (NTES) -- that come from top-ranked sectors too -- should realize the ongoing Fed-induced Santa Claus rally in 2023.
- 12/20/2023
|
Best Growth Stocks to Buy for December 20th
- MPTI, LZ and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 20, 2023.
- 12/20/2023
|
Best Growth Stocks to Buy for December 18th
- DVA, EAT and EG made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 18, 2023.
- 12/18/2023
|
5 Top Growth Stocks to Make the Most of Santa Claus Rally
- We have narrowed our search to five growth stocks that have solid upside left for the rest of 2023. These are: DOCU, DUOL, DVA, VRT, PLTR.
- 12/15/2023
|
5 Undervalued S&P 500 Stocks to Buy for 2024
- Investors seeking to tap the bullish momentum in the S&P 500 should invest in undervalued stocks like Everest Group (EG), Comcast (CMCSA), 3M Company (MMM), Molson Coors (TAP) and DaVita (DVA).
- 12/15/2023
|
5 Undervalued Stocks in the S&P 500 ETF to Buy for 2024
- Many stocks in the S&P 500 ETF may be undervalued and have the potential to rise toward their peak values.
- 12/11/2023
|
DVA or CHE: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both DaVita HealthCare (DVA) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
- 12/11/2023
|
Are Investors Undervaluing DaVita (DVA) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/08/2023
|
Top 5 Mid-Cap Stocks Likely to Turn Large-Cap in 2024
- We have narrowed our search to five mid-caps that have strong potential for 2024. These are: DVA, XPO, AIZ, EME, DUOL.
- 12/07/2023
|
Best Growth Stocks to Buy for December 7th
- EGHT, DVA and BBSI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 7, 2023.
- 12/07/2023
|
Best Growth Stocks to Buy for December 5th
- LMB, DVA and PK made it to the Zacks Rank #1 (Strong Buy) growth stocks list on December 5, 2023.
- 12/05/2023
|
Top 5 High-Flying S&P 500 Stocks of November With More Upside
- Five S&P 500 stocks with more potential are: IT, INTC, RCL, CBOE, DVA.
- 12/04/2023
|
4 Stocks Trading Near 52-Week High That Can Climb Further
- Investors target stocks that have been on a bullish run lately. Stocks like DVA, EAT, CNA and ITGR that are seeing price strength have a high chance of carrying the momentum forward.
- 11/29/2023
|
5 Finest PEG-Based Value Stocks to Buy Now
- Here are five stocks that match our screening criteria ??? FOXA, DVA, LDOS, BLD and ITRI.
- 11/28/2023
|
Only Have $100? 3 No-Brainer Stocks to Buy Right Now
- Despite the fear and concern that bear markets create, smart investors understand they are excellent buying opportunities. We don't know when they'll hit, how far they'll fall or how long they will last, but decades of data show the memory of every previous bear market was wiped clean by a bull market.
- 11/28/2023
|
Why You Should Add DaVita (DVA) Stock to Your Portfolio
- DaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock.
- 11/22/2023
|
Should Value Investors Buy DaVita (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 11/22/2023
|
Best Growth Stocks to Buy for November 16th
- MDV, LZ and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on November 16, 2023.
- 11/16/2023
|
All You Need to Know About DaVita HealthCare (DVA) Rating Upgrade to Strong Buy
- DaVita HealthCare (DVA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 11/10/2023
|
DaVita (DVA) Q3 Earnings & Revenues Top Estimates, Margins Up
- DaVita's (DVA) robust segmental revenues drive its third-quarter performance.
- 11/08/2023
|
DaVita Inc. (DVA) Q3 2023 Earnings Call Transcript
- DaVita Inc. (DVA) Q3 2023 Earnings Call Transcript
- 11/07/2023
|
Dialysis provider DaVita raises full-year profit outlook, shares rise
- Dialysis firm DaVita raises its full-year 2023 adjusted profit per share outlook after beating quarterly revenue estimates, on the back of strong demand, sending shares up nearly 6% in extended trading.
- 11/07/2023
|
Why Warren Buffett has done more to educate investors than any other corporate executive
- Warren Buffett, the CEO of Berkshire Hathaway, is world famous and a closely watched market force. Berkshire is a big shareholder of Apple, one of the seven big tech companies that currently dominate the U.S. stock market.
- 11/07/2023
|
DVA or CHE: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with DaVita HealthCare (DVA) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
- 11/07/2023
|
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 11/07/2023
|
DaVita (DVA) to Report Q3 Earnings: What's in the Offing?
- Improvement in U.S. dialysis treatments per day and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the third quarter.
- 11/03/2023
|
DaVita stock price forecast: Ozempic sell-off is an overreaction
- DaVita (NYSE: DVA) stock price has come under intense pressure in the past few days. The stock made a big dive on October 9th and crashed to a multi-month low of $71.45.
- 10/25/2023
|
Buffett's Bullish Bets: 3 Stocks Where Warren Has At Least a 25% Stake
- We know Warren Buffett likes to make big bets on business. Apple (NASDAQ: AAPL ) is famously one of the largest Warren Buffett stocks, accounting for nearly one-half of Berkshire Hathaway's (NYSE: BRK-A , NYSE: BRK-B ) holdings.
- 10/24/2023
|
DaVita Inc. Schedules 3rd Quarter 2023 Investor Conference Call
- DENVER , Oct. 17, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Tuesday, November 7, 2023, at 5:00 p.m. Eastern Time.
- 10/17/2023
|
DaVita says news of Ozempic's potential in treating kidney disease may have only limited impact for patients, says further studies will be needed
- Dialysis company DaVita Inc. DVA, -16.86% issued a statement on Thursday in response to the news Wednesday from Novo Nordisk that its Ozempic treatment for type 2 diabetes delayed the progression of chronic kidney disease (CKD) and lowered the risk of kidney and cardiovascular mortality in a trial. The news that the Danish company had halted the trial because of its efficacy sent the stocks of dialysis companies, including DaVita, lower on Wednesday.
- 10/12/2023
|
DaVita says Ozempic's early success in kidney trial to have 'limited application'
- Dialysis firm DaVita said on Thursday it believes that early success of Novo Nordisk's diabetes drug Ozempic in kidney disease trial will have "limited application" to overall patients suffering from chronic kidney disease.
- 10/12/2023
|
What other industries could weight loss drugs disrupt?
- Jared Holz, Mizuho health care sector strategist, joins the ‘Fast Money' traders to discuss Novo Nordisj's kidney trial outcomes and the impact of weight loss drugs on the health care sector.
- 10/11/2023
|
The 3 Widest Competitive Moats on Wall Street
- Competitive moats symbolize a company's sustainable advantage, protecting it from competitors and external threats. Three standout examples illustrate this principle vividly.
- 10/11/2023
|
Why Dialysis Stocks Plunged Today
- Novo Nordisk shares rallied after it announced it will stop its FLOW trial nearly a year earlier than expected after positive feedback on interim data for semaglutide's ability to treat kidney disease. The news sent dialysis products and services providers plunging.
- 10/11/2023
|
Ozempic Alert: New Trial Causes DaVita (DVA) Stock to Plunge 20%
- Ozempic may find yet another clinical use. The drug, developed by Danish pharmaceutical giant Novo Nordisk (NYSE: NVO ), has been making waves throughout the healthcare industry.
- 10/11/2023
|
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 10/11/2023
|
Ozempic Is Moving a Bunch of Stocks Wednesday Morning
- Markets were poised to move higher again on Wednesday morning. Shares of Novo Nordisk climbed on good news from a study of its drug Ozempic on kidney patients.
- 10/11/2023
|
Novo Nordisk Halts Ozempic Kidney Trial. Why It's Bad for DaVita.
- Novo Nordisk's Ozempic already is poised to disrupt a range of industries via its weight-loss benefits. Now it threatens companies which treat kidney failure.
- 10/11/2023
|
DaVita: Continued Economic Hurdles, Market Expectations May Be Correct
- DaVita Inc. stock has been heavily sold in '23, trading below its 50-day moving average for the past 8 weeks. The company lacks economic value, and its reinvestment runway looks limited, producing sub-standard returns on capital. The market expects modest earnings growth for DaVita, and it would appear that the stock is currently trading within its fair value range.
- 10/04/2023
|
DVA vs. CHE: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either DaVita HealthCare (DVA) or Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
- 10/04/2023
|
Buy These 3 Low-Beta Stocks to Navigate Volatility
- Stocks have faced pressure over the last several weeks, with continued uncertainty surrounding the economy weighing on investors' minds.
- 09/27/2023
|
4 Stocks Trading Near 52-Week High That Can Climb Further
- Investors target stocks that have been on a bullish run lately. Stocks like GIII, CEG, CWCO and DVA that are seeing price strength have a high chance of carrying the momentum forward.
- 09/22/2023
|
Is DaVita (DVA) Stock Outpacing Its Medical Peers This Year?
- Here is how DaVita HealthCare (DVA) and McKesson (MCK) have performed compared to their sector so far this year.
- 09/21/2023
|
New Strong Buy Stocks for September 19th
- DHI, DVA, KMTUY, ELAN and BWMX have been added to the Zacks Rank #1 (Strong Buy) List on September 19, 2023.
- 09/19/2023
|
Three Reasons to Add DaVita (DVA) Stock to Your Portfolio
- DaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock.
- 09/18/2023
|
DVA or CHE: Which Is the Better Value Stock Right Now?
- Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with DaVita HealthCare (DVA) and Chemed (CHE). But which of these two stocks offers value investors a better bang for their buck right now?
- 09/18/2023
|
Should Value Investors Buy DaVita (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 09/14/2023
|
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 09/06/2023
|
4 Stocks to Buy in a Booming Outpatient Home Health Industry
- Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, EHC, OPCH and RDNT are well-poised to gain.
- 09/01/2023
|
Change of Ownership? 3 S&P 500 Giants That Should Consider Selling
- U.S. Steel (NYSE: X ) announced on Aug. 13 that it was undertaking a strategic review to maximize shareholder value. Once the country's largest steelmaker, it was removed as a constituent of S&P 500 stocks in June 2014.
- 08/31/2023
|
Are Investors Undervaluing DaVita (DVA) Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/29/2023
|
7 Very Oversold Warren Buffett Stocks to Buy Right Now
- During times of market volatility, many investors look to see which stocks Warren Buffett is buying. Spoiler alert, you won't find him chasing the hottest AI stocks.
- 08/27/2023
|
3 Reasons to Retain DaVita (DVA) Stock to Your Portfolio
- DaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock.
- 08/14/2023
|
Three-Stock Lunch: Tyson Foods, Campbell Soup and DaVita
- Eva Ados, Eshares COO, joins ‘Power Lunch' to discuss three stocks: Tyson Foods, Campbell Soup and DaVita.
- 08/07/2023
|
DaVita Inc: A Healthcare Provider with Good Outperformance Potential
- DaVita Inc ( DVA , Financial), a leading player in the Healthcare Providers & Services industry, is currently trading at $115.08 with a market capitalization of $10.51 billion. The stock has seen a gain of 5.76% today and a 10.26% increase over the past four weeks.
- 08/07/2023
|
Contrarian Bull Note Boosts Dialysis Stock
- The shares of dialysis machine maker DaVita Inc (NYSE:DVA) are 6.6% higher to trade at $115.36 this morning, and earlier hit an 18-month high of $116.52.
- 08/07/2023
|
DaVita Inc: A Healthcare Stock with Good Outperformance Potential
- DaVita Inc ( DVA , Financial), a leading player in the Healthcare Providers & Services industry, is currently trading at $108.76 with a market capitalization of $9.86 billion. The stock has seen a gain of 7.09% today and an impressive 8.15% over the past four weeks.
- 08/04/2023
|
DaVita (DVA) Tops Q2 Earnings Estimates, Ups FY23 EPS View
- DaVita's (DVA) robust dialysis patient service drives its second-quarter performance.
- 08/04/2023
|
DaVita Inc. (DVA) Q2 2023 Earnings Call Transcript
- DaVita Inc. (NYSE:DVA ) Q2 2023 Earnings Conference Call August 3, 2023 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Joanna Gajuk - Bank of America Andrew Mok - UBS Pito Chickering - Deutsche Bank Lisa Clive - Bernstein Operator Good evening. My name is Michelle, and I will be your conference facilitator today.
- 08/03/2023
|
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
- DaVita HealthCare (DVA) came out with quarterly earnings of $2.08 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $2.30 per share a year ago.
- 08/03/2023
|
DaVita's stock gains after hours following earnings beat, outlook hike
- DaVita Inc. DVA, -0.40% shares rose in the extended session Thursday after the dialysis center company topped Wall Street estimates, and hiked its forecast for the year. DaVita shares rose as much as 5% after hours, following a 0.4% decline in the regular session to close at $101.56.
- 08/03/2023
|
DaVita (DVA) to Report Q2 Earnings: What's in the Offing?
- Improvement in U.S. dialysis treatments per day and cost-saving initiatives are likely to have boosted DaVita's (DVA) second quarter's top line.
- 08/01/2023
|
Best Growth Stocks to Buy for July 31st
- TOL, NSP and DVA made it to the Zacks Rank #1 (Strong Buy) growth stocks list on July 31, 2023.
- 07/31/2023
|
DVA vs. CHE: Which Stock Is the Better Value Option?
- Investors with an interest in Medical - Outpatient and Home Healthcare stocks have likely encountered both DaVita HealthCare (DVA) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
- 07/20/2023
|
Best Value Stocks to Buy for July 19th
- SOHO, DVA and PHM made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 19, 2023.
- 07/19/2023
|
DaVita HealthCare (DVA) is a Great Momentum Stock: Should You Buy?
- Does DaVita HealthCare (DVA) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 07/14/2023
|
Is DaVita (DVA) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 07/12/2023
|
DaVita (DVA) Hits 52-Week High: What's Driving the Stock?
- Investors are optimistic about DaVita's (DVA) strength in its kidney care.
- 07/11/2023
|
Wall Street Is Cautious on These 2 First Half Winners
- Lately, it seems like the only thing that can stop the U.S. equity markets is a holiday early close. Heading into the 4th of July celebration, major stock indices are enjoying a festive 2023 thanks to 1) waning expectations of a long anticipated recession and 2) retreating inflation.
- 07/06/2023
|
The 7 Most Undervalued Buffett Stocks to Buy Now: June 2023
- Plenty of investors are interested in the stocks that legendary investor Warren Buffett has selected for the Berkshire Hathaway (NYSE: BRK-A , NYSE: BRK-B ) equity portfolio. However, instead of buying every single stock in this category, you may want to focus mainly on the undervalued Buffett stocks instead.
- 07/02/2023
|
Top-Performing Stocks of Warren Buffett's Berkshire as of June
- According to current portfolio statistics, a Premium feature of GuruFocus, five stocks in Warren Buffett (Trades, Portfolio)'s first-quarter 13F equity portfolio that outperformed the Standard & Poor's 500 Index during the past six months include Nu Holdings Ltd. ( NU , Financial), Amazon.com Inc. ( AMZN , Financial), StoneCo Ltd.
- 06/23/2023
|
4 Stocks to Hold in a Challenging Outpatient Home Health Industry
- Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, CHE, AMED and ADUS are well poised to gain.
- 06/14/2023
|
Here's Why You Should Retain DaVita (DVA) Stock for Now
- Investors remain optimistic about DaVita (DVA) due to the strength of its DaVita Kidney Care.
- 06/01/2023
|
Warren Buffett Is Making A Mint On 7 Stocks That Pay No Dividends
- Warren Buffett likes to brag about dividends from S&P 500 stocks. But this year he's scoring gains with no dividend Warren Buffett stocks.
- 05/19/2023
|
Why Buffett Loves These 3 Stocks - American Express (NYSE:AXP), DaVita (NYSE:DVA)
- An interviewer once asked Warren Buffett about the worst trade he'd ever made
- 05/16/2023
|
Earnings Estimates Rising for DaVita HealthCare (DVA): Will It Gain?
- DaVita HealthCare (DVA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 05/12/2023
|
2 Top-Rated Medical Stocks to Buy After Earnings
- As we round out this week's earnings lineup, a few healthcare companies are standing out after topping their quarterly earnings expectations.
- 05/11/2023
|
DVA vs. CHE: Which Stock Should Value Investors Buy Now?
- Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with DaVita HealthCare (DVA) and Chemed (CHE). But which of these two companies is the best option for those looking for undervalued stocks?
- 05/10/2023
|
These 2 Stocks Are Popping -- and It Could Be Just the Beginning
- Markets eased lower at midday on Tuesday. Palantir Technologies has seen strong demand for its AI-related software product.
- 05/09/2023
|
DaVita (DVA) Tops Q1 Earnings Estimates, Ups FY23 EPS View
- DaVita's (DVA) robust revenues in both segments drive its first-quarter performance.
- 05/09/2023
|
DaVita Inc. (DVA) Q1 2023 Earnings Conference Call Transcript
- DaVita Inc. (NYSE:DVA ) Q1 2023 Earnings Conference Call May 8, 2023 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier J. Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Gary Taylor - Cowen Operator Good evening.
- 05/08/2023
|
DaVita (DVA) to Report Q1 Earnings: What's in the Offing?
- High labor costs and inflationary pressures are likely to have weighed on DaVita's (DVA) first-quarter top line.
- 05/04/2023
|
12 Stocks That Offer Growth, Value, and Momentum
- Why pick one factor or style of investing when you can have them all?
- 05/03/2023
|
DaVita Inc. to Participate in the Barclays 2023 Global Healthcare Conference
- DENVER , March 13, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference on Tuesday, March 14, 2023, at 3:05 p.m. EDT. To view the live webcast, visit the Barclays page here and create a free registration.
- 03/13/2023
|
DaVita: High Debt Load, And Increased Interest Expenses
- DaVita is a stock that has been in Warren Buffett's portfolio for many years. Now the company is under short-term pressure from higher patient costs, labor issues, higher interest expenses, and lower patient volumes.
- 02/27/2023
|
DaVita (DVA) Q4 Earnings Beat Estimates, Margins Down
- Despite DaVita's (DVA) robust revenues in its Other segment, its overall Q4 performance was soft.
- 02/23/2023
|
DaVita, Inc. (DVA) Q4 2022 Earnings Call Transcript
- DaVita, Inc. (NYSE:DVA ) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ET Company Participants Javier Rodriguez - CEO & Executive Director Joel Ackerman - CFO & Treasurer Conference Call Participants Andrew Mok - UBS Philip Chickering - Deutsche Bank Gary Taylor - Cowen and Company Kevin Fischbeck - Bank of America Merrill Lynch Operator Good evening. My name is Michelle, and I will be your conference facilitator today.
- 02/22/2023
|
DaVita HealthCare (DVA) Q4 Earnings Beat Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of 26.14% and 0.75%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/22/2023
|
DaVita (DVA) to Report Q4 Earnings: What's in the Offing?
- High labor costs, along with inflationary pressures, are likely to have weighed on DaVita's (DVA) fourth-quarter top line.
- 02/20/2023
|
Warren Buffett Refuses To Part With 21 Beloved Stocks
- Warren Buffett is increasingly willing to dump his lousy stocks. But there's a group of beloved S&P 500 stocks he won't sell.
- 02/17/2023
|
Betting On Biotech
- Active investors can navigate the boom or bust biotech sector with the help of strategies like C-suite buying, cash to value and cash flow. Passive investors seeking a defensive position might just purchase the VanEck Pharmaceutical ETF and call it a year.
- 02/10/2023
|
The 7 Best Beaten-Down Warren Buffett Stocks to Buy
- When it comes to Warren Buffett stocks to buy, the quintessential purchase is Berkshire Hathaway (NYSE: BRK-B ). After all, when you buy shares in Berkshire, you not only get a bunch of great operating businesses like BNSF Railway, Geico, Berkshire Energy and so many more, but you also get an equity portfolio currently worth more than $350.5 billion.
- 02/08/2023
|
DaVita Inc. Schedules 4th Quarter 2022 Investor Conference Call
- DENVER , Feb. 1, 2023 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter and full year results on Wednesday, February 22, 2023, at 5:00 p.m. Eastern Time.
- 02/01/2023
|
Final Trades: Stryker, DaVita, Biotech and more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 01/30/2023
|
Here's Why You Should Retain DaVita (DVA) Stock for Now
- Investors remain optimistic about DaVita (DVA) due to the strength in its DaVita Kidney Care.
- 01/25/2023
|
Sell These 3 Stocks and Kick These Overpaid CEOs Out of Your Portfolio
- If you're thinking about which stocks to sell heading into 2023, you might want to start with companies whose CEOs are overpaid. The Financial Times published an article in mid-December discussing how to pay executives in the age of stakeholder capitalism.
- 12/20/2022
|
Is the Options Market Predicting a Spike in DaVita (DVA) Stock?
- Investors need to pay close attention to DaVita (DVA) stock based on the movements in the options market lately.
- 12/16/2022
|
DaVita: A Favorite Of Berkshire Investment Manager Is Undervalued
- BRK has held shares in DVA since 2011, presumably picked by Ted Weschler. Debt levels have risen but the company has strong FCF and a track record of paying down debt aggressively when needed.
- 12/15/2022
|
DaVita: Shares Still Appear Cheap After Outlook Cut, Technicals Suggest Caution
- Healthcare stocks have been strong recently and for the year amid heightened volatility. One healthcare provider has dealt with an unfavorable SCOTUS ruling and a big EPS miss in recent months.
- 12/11/2022
|
These Are Warren Buffett's 12 Biggest Stock Mistakes This Year
- Most S&P 500 stock investors own a few turkeys this year. And Warren Buffett is no exception.
- 11/29/2022
|
DaVita Inc. (DVA) Q3 2022 Earnings Call Transcript
- DaVita Inc. (NYSE:DVA ) Q3 2022 Earnings Conference Call October 28, 2022 8:30 AM ET Company Participants Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Andrew Mok - UBS Kevin Fischbeck - Bank of America Pito Chickering - Deutsche Bank Justin Lake - Wolfe Research Operator Good morning. My name is Amanda, and I will be your conference facilitator today.
- 10/28/2022
|
Dialysis company DaVita stock suffering worst day in 22 years after big profit miss, disappointing outlook
- Shares of DaVita Inc. plummeted in active trading Friday, toward their worst performance in more than two decades, after the dialysis company reported third-quarter that fell well below expectations and slashed its full-year outlook, citing declining treatments and rising labor costs.
- 10/28/2022
|
DaVita (DVA) Q3 Earnings Lag Estimates, 2022 EPS View Cut
- DaVita's (DVA) Q3 performance gets a boost from strength in both its segments.
- 10/28/2022
|
DaVita HealthCare (DVA) Q3 Earnings and Revenues Lag Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of -12.12% and 1.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 10/28/2022
|
DaVita (DVA) to Report Q3 Earnings: What's in the Offing?
- High labor costs, along with inflationary pressures, are likely to have weighed on DaVita's (DVA) third quarter's top line.
- 10/21/2022
|
7 Warren Buffett Stocks to Buy and Hold for the Next Decade
- Warren Buffet's philosophy relies on identifying stocks to buy and hold. He believes that the best names to buy and hold are those of undervalued companies that have high chances of being successful over the long term.
- 10/17/2022
|
DaVita Inc. Schedules 3rd Quarter 2022 Investor Conference Call
- DENVER , Oct. 14, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Friday, October 28, 2022, at 8:30 a.m. Eastern Time.
- 10/14/2022
|
DaVita: Solid Valuation And Cash Flow, Price Recovering After SCOTUS Ruling
- The Health Care sector has been a source of relative safety during this tumultuous September. While some large-caps in the space are catching bids, one smaller health care services and facilities company is sharply lower in 2022.
- 09/28/2022
|
The 7 Most Undervalued Mid-Cap Stocks to Buy Now
- It's up for debate whether the stock market downturn has reached or is close to reaching the “bottoming out” stage, but there are many opportunities out there. While most of the best opportunities are among stocks of the small-cap/”unknown” variety, there are also plenty of undervalued mid-cap stocks to buy now trading at low valuations.
- 09/26/2022
|
The 10 Cheapest Warren Buffett Stocks
- These Berkshire Hathaway holdings sport forward-year price-to-earnings (P/E) ratios of 4.8 to 9.2.
- 09/12/2022
|
7 Undervalued Stocks That Everyone Is Missing Out On
- Undervalued stocks are businesses that trade below their intrinsic value. Thomas Chua is the author of the 3-Bullet Sunday investment newsletter.
- 08/19/2022
|
Down 26%, Is This Buffett Stock a Buy?
- Warren Buffett loves to own cash-generating "toll bridge" companies. DaVita qualifies on both counts.
- 08/08/2022
|
DaVita (DVA) Beats on Q2 Earnings, Reiterates FY22 EPS View
- DaVita (DVA) records an overall solid Q2 performance owing to strength in its Other segment's revenues and uptick in total U.S. dialysis treatments.
- 08/02/2022
|
DaVita Inc. (DVA) CEO Javier Rodriguez on Q2 2022 Results - Earnings Call Transcript
- DaVita Inc. (NYSE:DVA ) Q2 2022 Earnings Conference Call August 1, 2022 5:00 PM ET Corporate Participants Joel Ackerman - Chief Financial Officer and Treasurer Javier Rodriguez - Chief Executive Officer Conference Call Participants Kevin Fischbeck - Bank of America Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Sarah James - Barclays Gary Taylor - Cowen Operator Good evening. My name is Michelle, and I'll be your conference facilitator today.
- 08/01/2022
|
DaVita HealthCare (DVA) Tops Q2 Earnings Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of 9% and 0.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/01/2022
|
3 No-Brainer Warren Buffett Stocks That Will Undeniably Profit from the Bear Market
- These unstoppable companies can succeed in pretty much any economic condition.
- 07/27/2022
|
DaVita (DVA) to Report Q2 Earnings: What's in the Offing?
- Supply constraints, along with inflationary pressures, is likely to have weighed on DaVita's (DVA) second quarter's top line.
- 07/25/2022
|
15 Stocks Warren Buffett Has Held for at Least 10 Years
- Patience plays a big role in the Oracle of Omaha's investing philosophy.
- 07/25/2022
|
3 Reasons to Retain DaVita (DVA) Stock in Your Portfolio
- Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care.
- 07/19/2022
|
DaVita Inc. Schedules 2nd Quarter 2022 Investor Conference Call
- DENVER , July 18, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Monday, August 1, 2022, at 5:00 p.m. Eastern Time.
- 07/18/2022
|
DaVita: Valuation Turning Attractive
- DaVita's recent performance highlights its exposure to regulatory risk and its limitations as a business to proactively generate growth. We expect to see a recovery YoY into FY12/2023 driven primarily by normalizing conditions.
- 07/16/2022
|
5 Undervalued Predictable Health Care Stocks
- U.S. market indexes kicked off the week lower as investors prepare for the start of second-quarter earnings season.
- 07/11/2022
|
2 Potential Berkshire Acquisitions
- Something I have been thinking about recently is the possibility of Berkshire Hathaway ( BRK.A , Financial) ( BRK.B , Financial) and Warren Buffett (Trades, Portfolio) making an offer for a company that has seen its share price decline significantly over the past couple of months.
- 07/07/2022
|
3 Stocks Warren Buffett Owns the Biggest Percentage Stakes In (Hint: Apple Isn't 1 of Them)
- Based on how big a slice of the pie is owned, these could be viewed as Warren Buffett's favorite stocks.
- 06/30/2022
|
6 Stocks Insiders Are Buying Now
- These are 6 stocks insiders are buying now. Execs buying shares now want to get in before Q2 earnings come out - a good sign for investors.
- 06/28/2022
|
Will Buffett's Tech Losses Lead Him to Sell?
- Even the great Warren Buffett (Trades, Portfolio) has suffered losses during the tech sector sell-off that has gripped markets in 2022. According to Berkshire Hathaway's ( BRK.B , Financial) ( BRK.A , Financial) latest 13F report, the conglomerate owned a number of technology stocks at the end of the first quarter of 2022, and some of them have declined in value by as much as 40%.
- 06/24/2022
|
DaVita HealthCare (DVA) Surges 6%: Is This an Indication of Further Gains?
- DaVita HealthCare (DVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
- 06/23/2022
|
DaVita Inc. Schedules Special Investor Conference Call
- DENVER , June 22, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today it will hold a special conference call with investors on Thursday, June 23, 2022, at 8:45 a.m. Eastern Time.
- 06/22/2022
|
U.S. Supreme Court rules against DaVita over dialysis coverage
- The U.S. Supreme Court on Tuesday rejected kidney dialysis provider DaVita Inc's claims that an Ohio hospital's employee health plan discriminates against patients with end-stage renal disease by reimbursing them at low rates in hopes they would switch to Medicare.
- 06/21/2022
|
3 Stocks to Watch From a Buoyant Outpatient Home Health Industry
- Despite the COVID-19 pandemic-induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and USPH are well-poised to gain from the prospects.
- 06/10/2022
|
Medtronic, DaVita To Jointly Form Kidney Health-Focused Company
- Medtronic plc (NYSE: MDT) and DaVita Inc (NYSE: DVA) intend to form a new, independent kidney care-focused medical device company (NewCo). NewCo will focus on developing a broad suite of novel kidney care products and solutions, including future home-based products.
- 05/26/2022
|
Reasons to Retain DaVita (DVA) Stock in Your Portfolio For Now
- Investors remain optimistic about DaVita (DVA) due to strength in its DaVita Kidney Care and impressive overseas growth.
- 05/20/2022
|
DaVita Offers Stability During Market Volatility
- With steady revenues and a predictable earnings profile, DaVita is a perfect example of a stock which could add stability to investors' portfolios during periods of volatility. While the company has a hefty debt load, the company's maturity schedule and cash flow offer management a lot of flexibility, addressing the larger near-term maturities in 2024 and 2026.
- 05/12/2022
|
DaVita Inc. (DVA) CEO Javier Rodriguez on Q1 2022 Results - Earnings Call Transcript
- DaVita Inc. (NYSE:DVA ) Q1 2022 Results Conference Call May 5, 2022 5:00 PM ET Company Participants Joel Ackerman - CFO and Treasurer Javier Rodriguez - CEO Conference Call Participants Kevin Fischbeck - Bank of America Justin Lake - Wolfe Research Pito Chickering - Deutsche Bank Operator Good evening. My name is Missy, and I'll be your conference facilitator today.
- 05/05/2022
|
DaVita HealthCare (DVA) Q1 Earnings and Revenues Lag Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of -12.97% and 2.10%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2022
|
Earnings Results: DaVita stock falls as higher wages, missed treatments push earnings below Street expectations
- DaVita Inc. shares dropped in the extended session Thursday after the dialysis-service provider's earnings fell short of Wall Street estimates as the company said COVID-19 factors and higher wages dinged its bottom line.
- 05/05/2022
|
5 Undervalued Buffett Stocks Ahead of Annual Meeting
- Investors around the world are making the journey to Omaha, Nebraska to attend Berkshire Hathaway's ( BRK.A , Financial)( BRK.B , Financial) annual shareholder meeting this weekend, which is being held in person for the first time in two years.
- 04/28/2022
|
DaVita Inc. Schedules 1st Quarter 2022 Investor Conference Call
- DENVER , April 21, 2022 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time.
- 04/21/2022
|
DaVita and its former CEO acquitted of antitrust charges
- A jury in Denver, Colorado, acquitted dialysis provider DaVita and its former CEO Kent Thiry on Friday of charges that they conspired with competitors not to hire each other's employees.
- 04/15/2022
|
Here's Why You Should Hold on to DaVita (DVA) Stock Now
- DaVita (DVA) continues to gain traction from its strong international presence and solid DaVita Kidney Care business. However, integration risks are a woe.
- 03/16/2022
|
Is DaVita (DVA) a Suitable Value Investor Stock Now?
- Let's see if DaVita (DVA) stock is a good choice for value-oriented investors right now from multiple angles.
- 03/03/2022
|
7 Berkshire Hathaway Stock Picks to Buy If You Wanna Be Like Warren
- With market uncertainty ratcheting up, and more speculative names under pressure, now may be the time to cycle into Warren Buffett stocks. The post 7 Berkshire Hathaway Stock Picks to Buy If You Wanna Be Like Warren appeared first on InvestorPlace.
- 02/25/2022
|
DaVita's (DVA) Q4 Earnings Surpass Estimates, Margins Up
- DaVita's (DVA) strength in dialysis patient service revenues drives its Q4 top line.
- 02/11/2022
|
DaVita Inc.'s (DVA) CEO Javier Rodriguez on Q4 2021 Results - Earnings Call Transcript
- DaVita Inc.'s (DVA) CEO Javier Rodriguez on Q4 2021 Results - Earnings Call Transcript
- 02/10/2022
|
DaVita HealthCare (DVA) Surpasses Q4 Earnings and Revenue Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of 12.22% and 1%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/10/2022
|
3 Stocks to Bank on the Buoyant Outpatient Home Health Industry
- Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and USPH are well-poised to gain from the prospects.
- 02/08/2022
|
DaVita (DVA) to Report Q4 Earnings: What's in the Offing?
- Sustained momentum with respect to inpatient dialysis revenue per treatment is likely to have aided DaVita's (DVA) top line in the fourth quarter despite the ongoing pandemic-led business challenges.
- 02/04/2022
|
5 Top Health Care Stocks To Watch Before February 2022
- Should investors be paying more attention to these health care stocks?
- 01/27/2022
|
DaVita's (DVA) Collaboration to Aid in Kidney Care Needs
- DaVita's (DVA) work with transplant providers and kidney doctors is likely to slow CKD progression and bolster access to home dialysis and kidney transplantation.
- 01/26/2022
|
Forget DaVita (DVA), Buy These 3 Lucrative Medical Care Stocks
- With stocks offering dialysis services, including DaVita (DVA), facing several issues, it would be prudent to invest in medical care and services stocks like DGX, AMN and CODX instead for 2022.
- 12/30/2021
|
New Strong Sell Stocks for December 28th
- DVA, CSII, BYND, AVYA, and GFF have been added to the Zacks Rank #5 (Strong Sell) List on December 28, 2021.
- 12/28/2021
|
4 Warren Buffett Stocks Trading Near 52-Week Lows
- As investors grapple with market volatility over the new coronavirus variant, four stocks in Berkshire Hathaway Inc. ( BRK.A , Financial)( BRK.B , Financial) CEO Warren Buffett (Trades, Portfolio)'s equity portfolio that have high business predictability and are trading near 52-week lows are Globe Life Inc. ( GL , Financial), DaVita Inc. ( DVA , Financial), Mastercard Inc. ( MA , Financial) and Visa Inc. ( V , Financial).
- 12/02/2021
|
New Strong Sell Stocks for November 29th
- DVA, NVST, WWD, PHR, and ROAD have been added to the Zacks Rank #5 (Strong Sell) List on November 29, 2021
- 11/29/2021
|
New Strong Sell Stocks for November 19th
- AMED, CSII, DVA, GFF, and LTRX have been added to the Zacks Rank #5 (Strong Sell) List on November 19, 2021.
- 11/19/2021
|
DaVita Clinical Research to Present New Findings at American Society of Nephrology Kidney Week 2021
- DENVER, Nov. 4, 2021 /PRNewswire/ -- DaVita Clinical Research (DCR) will present eight research abstracts from company representatives and medical professionals during the American Society of Nephrology (ASN) Kidney Week occurring Nov. 4–7, 2021. ASN Kidney Week 2021 will convene more than 13,000 kidney care professionals from around the world in a virtual format to discuss advancements in the field of nephrology.
- 11/04/2021
|
New Strong Sell Stocks for November 3rd
- TEAM, DVA, FLS, JD, and SBUX have been added to the Zacks Rank #5 (Strong Sell) List on November 3, 2021.
- 11/03/2021
|
Will DaVita Stock Rebound After A 10% Fall In A Month?
- The stock price of DaVita Healthcare (NYSE: DVA), a medical services company providing kidney dialysis services, has seen a fall of 7% last week, while it is down 10% in a month. The company recently announced its Q3 results with revenue of $2.9 billion, in-line with the consensus estimates.
- 11/03/2021
|
DaVita's (DVA) CEO Javier Rodriguez on Q3 2021 Results - Earnings Call Transcript
- DaVita's (DVA) CEO Javier Rodriguez on Q3 2021 Results - Earnings Call Transcript
- 10/28/2021
|
DaVita HealthCare (DVA) Q3 Earnings Top Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of 6.79% and -0.04%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 10/28/2021
|
DaVita Inc. Schedules Virtual Capital Markets Day for November 16, 2021
- DENVER, Oct. 19, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will host a virtual Capital Markets Day on Tuesday, November 16, 2021, from 10:00 a.m. to 12:00 p.m.
- 10/19/2021
|
DaVita Inc. Schedules 3rd Quarter 2021 Investor Conference Call
- DENVER, Oct. 19, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss third quarter results on Thursday, October 28, 2021, at 5:00 p.m. Eastern Time.
- 10/19/2021
|
3 Stocks for Growth-Oriented Investors
- Growth-oriented investors could be interested in the following stocks, since they represent businesses with price-earnings ratios below 20 and recorded significant improvements in trailing 12-month earnings per share over the past year.
- 10/18/2021
|
DaVita Climate Action Goals Approved by the Science Based Target Initiative
- DENVER, Oct. 11, 2021 /PRNewswire/ -- DaVita furthers commitment to climate action goals with validation from the Science Based Targets initiative (SBTi). The organization has approved two goals: Supply chain partners representing 70% of emissions will set climate change goals by 2025 Reduce its carbon emissions by 50% by 2025 "Our environmental goals proactively address our contribution to climate change," said Misha Palecek, chief transformation officer for DaVita.
- 10/11/2021
|
DaVita Kidney Care Names New Chief Nursing Officer
- DENVER, Sept. 16, 2021 /PRNewswire/ -- During Nephrology Nurses Week, DaVita Kidney Care begins a new chapter for its nursing program by announcing Tina Livaudais as the kidney care provider's chief nursing officer (CNO).
- 09/16/2021
|
7 Top Stocks To Buy And Hold Forever
- Wall Street keeps reminding us of the benefits of stocks to buy and hold since the early weeks of the pandemic. And here are a few to watch.
- 08/27/2021
|
3 Warren Buffett Stocks to Buy in August
- These names offer growth potential along with income.
- 08/10/2021
|
DaVita (DVA) Beats on Q2 Earnings, Raises 2021 EPS View
- DaVita's (DVA) strength in dialysis patient service revenues drives its Q2 top line.
- 08/04/2021
|
DaVita's (DVA) CEO Javier Rodriguez on Q2 2021 Results - Earnings Call Transcript
- DaVita's (DVA) CEO Javier Rodriguez on Q2 2021 Results - Earnings Call Transcript
- 08/03/2021
|
DaVita HealthCare (DVA) Q2 Earnings and Revenues Top Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of 23.36% and 1.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 08/03/2021
|
DaVita: Q2 Earnings Insights
- Shares of DaVita (NYSE:DVA) moved higher in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 35.38% year over year to $2.64, which beat the estimate of $2.18.
- 08/03/2021
|
The 7 Best Warren Buffett Stocks to Buy in August and Hold for Years
- These Buffett stocks are suitable for a wide range of retail portfolios. Check out 7 of the Omaha Oracle's top stocks to buy for August.
- 07/29/2021
|
DaVita (DVA) to Report Q2 Earnings: What's in the Offing?
- Sustained momentum with respect to U.S. dialysis revenue per treatment is likely to have aided DaVita's (DVA) top line in the second quarter despite ongoing pandemic-led higher PPE costs.
- 07/28/2021
|
DaVita Inc. Schedules 2nd Quarter 2021 Investor Conference Call
- DENVER, July 21, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 3, 2021, at 5:00 p.m. Eastern Time.
- 07/21/2021
|
DaVita and its former CEO indicted, Justice Department charges illegal ‘no poaching' deals with rivals
- Dialysis and kidney-care giant DaVita Inc. and its former chief executive were charged this week with conspiring with competing companies to not solicit one another's employees.
- 07/15/2021
|
4 GARP Stocks to Scoop Up for Maximum Returns
- If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
- 07/02/2021
|
Here's How Warren Buffett's Portfolio Jumped Almost 10% in Q2
- The value of Warren Buffett's stock holdings rose by 9.5% between its closing values on March 31 and June 30.
- 07/01/2021
|
DVA or AMED: Which Is the Better Value Stock Right Now?
- DVA vs. AMED: Which Stock Is the Better Value Option?
- 06/21/2021
|
5 GARP Stocks for a Winning Portfolio
- Growth at a reasonable price or GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount.
- 06/18/2021
|
5 Stocks With Warren Buffett as the Largest Shareholder
- Warren Buffett's Berkshire Hathaway Inc. (NYSE: BRK-B) portfolio includes nearly four dozen stocks.
- 06/18/2021
|
Save Your Portfolio From Inflation With Four Healthcare Stocks
- Healthcare stocks with long-term growth visibility can be important additions to investment portfolio when inflation runs high.
- 06/17/2021
|
Here's Why You Should Add DaVita (DVA) Stock to Your Portfolio
- Investors continue to be optimistic about DaVita (DVA) on its slew of tie-ups and strength in its kidney care business.
- 06/17/2021
|
4 Warren Buffett Holdings Trading at Low Price-to-Free Cash Flow Ratios
- According to the All-in-One Screener, a Premium feature of GuruFocus, four stocks in Berkshire Hathaway Inc.'s ( BRK.A , Financial)( BRK.B , Financial) equity portfolio that have high profitability and are trading at attractive price-to-free cash flow ratios are AbbVie Inc. ( ABBV , Financial), The Kroger Co. ( KR , Financial), DaVita Inc. ( DVA , Financial) and Globe Life Inc. ( GL , Financial).
- 06/16/2021
|
These 10 Stocks Make Up 85% of Warren Buffett's Portfolio
- Diversification isn't necessary if you know what you're doing, according to the Oracle of Omaha.
- 06/16/2021
|
DaVita's (DVA) Deal to Aid Patients in Kidney Transplantation
- DaVita (DVA) and NKF collaborate to help kidney patients seeking a living donor, thereby improving health equity in kidney transplant process.
- 06/14/2021
|
5 Probable MedTech Winners Post-COVID on Discounted PEG
- Here are some MedTech stocks with favorable PEG ratio, which are expected to provide gains in 2021.
- 06/11/2021
|
DaVita and the National Kidney Foundation Join Forces to Improve Health Equity in Kidney Transplantation
- NEW YORK, June 10, 2021 /PRNewswire/ -- DaVita Kidney Care and the National Kidney Foundation (NKF) today announced their collaboration in launching an innovative, yearlong pilot aimed at improving health equity in kidney transplantation with a newly-developed program within NKF's THE BIG ASK: THE BIG GIVE platform. "Many people never find a living donor simply because they are afraid to ask," said Kevin Longino, CEO, National Kidney Foundation and a kidney transplant patient.
- 06/10/2021
|
DVA vs. AMED: Which Stock Is the Better Value Option?
- DVA vs. AMED: Which Stock Is the Better Value Option?
- 06/04/2021
|
Virtual Support Groups Create Community for DaVita Home Dialysis Patients
- DENVER, June 2, 2021 /PRNewswire/ -- DaVita Kidney Care , a leading provider of home dialysis, launched virtual support groups through DaVita Care Connect®, a mobile health platform designed for home dialysis patients, to help create community and belonging for those treating at home. "Patients treating at home sometimes feel isolated and miss connecting with other people they feel they can relate to, which causes some patients to leave home treatment," said Dr. Martin Schreiber, chief medical officer for DaVita Home Modalities.
- 06/02/2021
|
3 Stocks to Bank on Rebounding Outpatient Home Health Industry
- 3 Stocks to Bank on Rebounding Outpatient Home Health Industry
- 05/25/2021
|
DVA vs. AMED: Which Stock Should Value Investors Buy Now?
- DVA vs. AMED: Which Stock Is the Better Value Option?
- 05/19/2021
|
Extraordinary Nurses at DaVita Kidney Care Honored with DAISY Awards
- DENVER, May 13, 2021 /PRNewswire/ -- DaVita Kidney Care today announced that 60 of its nephrology nurses were honored with The DAISY Award for Extraordinary Nurses® during National Nurses Week. The award is part of the DAISY Foundation's mission to recognize the extraordinary, compassionate care that nurses provide to patients and families every day.
- 05/13/2021
|
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
- Investor confidence is high on the DaVita (DVA) stock, courtesy of its solid prospects.
- 05/12/2021
|
DaVita to Further Elevate its Home Dialysis Care Experience with New Baxter Technology
- DENVER, May 10, 2021 /PRNewswire/ -- DaVita Kidney Care today announced the expansion of its home kidney care program to include the HomeChoice Claria Automated Peritoneal Dialysis (APD) system enabled by Sharesource remote patient monitoring from Baxter International Inc., a global innovator in renal care. This new technology further enhances DaVita's home dialysis program and is another important step forward to enable more patients to choose to treat their kidney failure at home.1 "With more than two decades of experience as the leading home dialysis provider, we know consistent communication between patients and care teams is crucial for building trust and confidence," said Dr. Martin Schreiber, chief medical officer for DaVita home modalities.
- 05/10/2021
|
DaVita (DVA) Q1 Earnings Beat Estimates, Revenues Miss Mark
- DaVita's (DVA) net dialysis and related lab-patient service revenues rise in Q1.
- 04/30/2021
|
DaVita's (DVA) CEO Javier Rodriguez on Q1 2021 Results - Earnings Call Transcript
- DaVita's (DVA) CEO Javier Rodriguez on Q1 2021 Results - Earnings Call Transcript
- 04/29/2021
|
DaVita HealthCare (DVA) Surpasses Q1 Earnings Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of 16.11% and -0.22%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 04/29/2021
|
Recap: DaVita Q1 Earnings
- Shares of DaVita (NYSE:DVA) moved lower in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 14.21% year over year to $2.09, which beat the estimate of $1.80.
- 04/29/2021
|
DaVita Solidifies Commitment to ESG, Sets 2025 Goals
- DENVER, April 27, 2021 /PRNewswire/ -- DaVita Inc. today announced its 2025 Environmental, Social and Governance (ESG) goals and released its new ESG reports, bolstering its commitment to corporate citizenship and helping create healthy communities. DaVita's ESG program builds upon existing efforts to transform care, fight climate change and create a diverse community where everyone feels they belong.
- 04/27/2021
|
DaVita Inc. Schedules 1st Quarter 2021 Investor Conference Call
- DENVER, April 22, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, April 29, 2021, at 5:00 p.m. Eastern Time.
- 04/22/2021
|
Blue Cross and Blue Shield of Minnesota Launches Program with DaVita's VillageHealth to Improve Care for Members with Kidney Disease
- EAGAN, Minn., April 12, 2021 /PRNewswire/ -- Blue Cross and Blue Shield of Minnesota (Blue Cross) today announced the launch of an innovative new program with VillageHealth − a DaVita integrated kidney care program − that addresses the holistic health needs of certain eligible members with chronic kidney disease (CKD) or end stage kidney disease (ESKD).
- 04/12/2021
|
5 Health Care Stocks Boosting Earnings
- The following health care companies have grown their earnings per share over a five-year period. According to the GuruFocus discounted cash flow calculator as of March 31, all of them also trade with a margin of safety.
- 03/31/2021
|
DaVita (DVA) Partners With Fresenius, Boost Home Dialysis Care
- DaVita's (DVA) recent collaboration will help patients benefit from the portability, dependability and flexibility of NxStage home machines, designed to be easy to use.
- 03/29/2021
|
DaVita Shares Strategy for Achieving a Diverse Community Where Everyone Belongs
- DENVER, March 29, 2021 /PRNewswire/ -- DaVita today published its inaugural Diversity & Belonging (D&B) report, which discloses its diversity metrics and roadmap for delivering its vision of cultivating "a diverse Village where everyone belongs." "Fostering an environment that is rich in diversity and where we all belong is imperative to our culture and how we connect with each other and our patients every day," said Javier Rodriguez, CEO for DaVita Inc. "Publishing this report not only underscores the seriousness with which we take diversity and belonging, but it also holds us accountable for making continued and intentional forward progress.
- 03/29/2021
|
BofA Downgrades DaVita On Low Exposure to Volume Rebound
- Since dialysis is a stable business, Davita Inc (NYSE: DVA) remained resilient during the pandemic. However, now with acceleration in volumes is poised to begin, the company “is not as levered to the expected utilization rebound as peers,” according to BofA Securities.
- 03/26/2021
|
DaVita Statement on Government's Nationwide Program to Vaccinate Dialysis Patients
- DENVER, March 25, 2021 /PRNewswire/ -- Today, the Biden administration announced a new partnership with dialysis providers to provide COVID-19 vaccinations to people receiving dialysis and health care personnel in outpatient dialysis centers. DaVita Kidney Care will receive a portion of this allocation and will work with other providers to make vaccines available in dialysis centers across the country.
- 03/25/2021
|
DaVita Kidney Care Expands Use of NxStage Home Hemodialysis Machines from Fresenius Medical Care
- WALTHAM, Mass. and DENVER, March 23, 2021 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA) and DaVita Kidney Care today announced an expanded agreement to provide home dialysis technology—including NxStage home hemodialysis (HHD) machines, dialysis supplies, and a connected health platform—to DaVita patients across the United States.
- 03/23/2021
|
DaVita HealthCare (DVA) Down 4.3% Since Last Earnings Report: Can It Rebound?
- DaVita HealthCare (DVA) reported earnings 30 days ago. What's next for the stock?
- 03/13/2021
|
DaVita Inc. to Participate in the 2021 Barclays Global Healthcare Conference
- DENVER, March 9, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced today that the company will participate in the 2021 Barclays Global Healthcare Conference. Joel Ackerman, DaVita's Chief Financial Officer, will answer questions in a virtual fireside chat on Wednesday, March 10,...
- 03/09/2021
|
DaVita Inc. Announces Add-On Offering of $750 Million Senior Notes
- DENVER, Feb. 24, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private add-on offering of $750 million aggregate principal amount of its 4.625% senior notes due June 1, 2030 (the "notes"), subject to market and other conditions. The notes...
- 02/24/2021
|
Francis Chou's Top 4 Sells of the 4th Quarter
- Francis Chou (Trades, Portfolio), manager of Chou Associates Management, disclosed last week that his firm's top four sells during the fourth quarter of 2020 included the closure of its position in Spirit Airlines Inc. (NYSE:SAVE) and Allegiant Travel Co. (NASDAQ:ALGT) and a reduction in its holding of DaVita Inc. (NYSE:DVA) and Goldman Sachs Group Inc. (NYSE:GS).
- 02/23/2021
|
DaVita (DVA) Q4 Earnings and Revenues Fall Shy of Estimates
- DaVita's (DVA) bottomline in Q4 declines year over year.
- 02/12/2021
|
DaVita, Inc. (DVA) CEO Javier Rodriguez on Q4 2020 Results - Earnings Call Transcript
- DaVita, Inc. (DVA) CEO Javier Rodriguez on Q4 2020 Results - Earnings Call Transcript
- 02/11/2021
|
DaVita HealthCare (DVA) Misses Q4 Earnings and Revenue Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of -9.73% and -1.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/11/2021
|
Recap: DaVita Q4 Earnings
- Shares of DaVita (NYSE:DVA) decreased after-market trading after the company reported Q4 results. Quarterly Results Earnings per share fell 10.22% year over year to $1.67, which missed the estimate of $1.87.
- 02/11/2021
|
DVA Investor Alert: Kyros Law is Filing Legal Claims on Behalf of Davita Inc (NYSE:DVA) Investors
- BOSTON, Feb. 6, 2021 /PRNewswire/ -- Kyros Law Offices is alerting investors of Davita Inc (NYSE:DVA) that the deadline in filing claims from the investor lawsuit settlement against the company is fast approaching. The company has agreed to settle a shareholder lawsuit filed against it by...
- 02/06/2021
|
DaVita (DVA) to Report Q4 Earnings: What's in the Offing?
- Solid performance by net dialysis and the related lab patient service segment is likely to have contributed to DaVita's (DVA) top line in the fourth quarter.
- 02/05/2021
|
DaVita Inc. Schedules 4th Quarter 2020 Investor Conference Call
- DENVER, Jan. 29, 2021 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss fourth quarter results on Thursday, February 11, 2021, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same...
- 01/29/2021
|
3 Outpatient Home Health Stocks Set to Ride the Industry's Upturn
- 3 Outpatient Home Health Stocks Set to Ride the Industry's Upturn
- 01/20/2021
|
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
- Investor confidence is high on DaVita (DVA) stock, driven by its solid prospects.
- 01/04/2021
|
Is DaVita HealthCare (DVA) Stock Undervalued Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/31/2020
|
DVA vs. CHE: Which Stock Is the Better Value Option?
- DVA vs. CHE: Which Stock Is the Better Value Option?
- 12/29/2020
|
Should Value Investors Buy DaVita HealthCare (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 12/15/2020
|
10 Undervalued Stocks to Buy That Are Preparing to Blast Off
- Some reasonably cheap stocks are growth stocks in disguise. If you're looking for undervalued stocks, these 10 are about to take off.
- 12/14/2020
|
The 10 Most Reliable Value Stocks to Buy for 2021
- As uncertainty continues and growth stocks remain richly priced, these 10 value stocks could be your ticket to gains in 2021. The post The 10 Most Reliable Value Stocks to Buy for 2021 appeared first on InvestorPlace.
- 12/11/2020
|
Why DaVita (DVA) Could Be an Impressive Growth Stock
- If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider DaVita (DVA).
- 11/27/2020
|
Is DaVita (DVA) Outperforming Other Medical Stocks This Year?
- Is (DVA) Outperforming Other Medical Stocks This Year?
- 11/16/2020
|
Were These Hedge Funds Wrong About Dumping DaVita Inc (DVA)?
- Many prominent investors, including Warren Buffett, David Tepper and Stan Druckenmiller, have been cautious regarding the current bull market and missed out as the stock market reached another high in recent weeks. On the other hand, technology hedge funds weren't timid and registered double digit market beating gains. Financials, energy and industrial stocks aren't doing great but many of the stocks that delivered strong returns since March are still going very strong and hedge funds actually increased their positions in these stocks. In this article we will find out how hedge fund sentiment to DaVita Inc (NYSE:DVA) changed recently.
- 11/10/2020
|
DaVita Responds to Proposition 23 in California
- SACRAMENTO, Calif., Nov. 4, 2020 /PRNewswire/ -- DaVita Kidney Care, a leading provider of kidney care services in the United States, issued the following statement: "We are grateful that Californians voted down Proposition 23, a harmful ballot measure that could have jeopardized access...
- 11/04/2020
|
DaVita, Inc. (DVA) CEO Javier Rodriguez on Q3 2020 Results - Earnings Call Transcript
- DaVita, Inc. (DVA) CEO Javier Rodriguez on Q3 2020 Results - Earnings Call Transcript
- 10/29/2020
|
DaVita (DVA) Set to Announce Quarterly Earnings on Thursday
- DaVita (NYSE:DVA) is scheduled to be announcing its earnings results after the market closes on Thursday, October 29th. Analysts expect the company to announce earnings of $1.49 per share for the quarter. DaVita has set its FY 2020 After-Hours guidance at 6.25-6.75 EPS and its FY20 guidance at $6.25-$6.75 EPS.Parties interested in listening to the […]
- 10/22/2020
|
3 Warren Buffett Stocks Worth Buying Now | The Motley Fool
- Many Warren Buffett stocks remain buys.
- 10/20/2020
|
Envestnet Asset Management Inc. Acquires 4,030 Shares of DaVita Inc. (NYSE:DVA)
- Envestnet Asset Management Inc. raised its holdings in DaVita Inc. (NYSE:DVA) by 1.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 212,676 shares of the company’s stock after acquiring an additional 4,030 shares during the period. Envestnet Asset Management […]
- 10/15/2020
|
DaVita: Potential For Double-Digit Returns, Powered By Buybacks And An Attractive Valuation (NYSE:DVA)
- DaVita's business model is able to provide the company with very reliable and stable revenues, as patients need their dialysis treatment on a constant basis.
- 10/14/2020
|
COVID-19's impact to Global Hemodialysis & Peritoneal Dialysis market Report 2020, Forecast to 2025
- Oct 09, 2020 (The Expresswire) --
Global “Hemodialysis and Peritoneal Dialysis market” competitive landscape provides particulars and data information by...
- 10/09/2020
|
DaVita Inc. (NYSE:DVA) Shares Acquired by First Hawaiian Bank
- First Hawaiian Bank increased its holdings in DaVita Inc. (NYSE:DVA) by 19.3% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 7,030 shares of the company’s stock after acquiring an additional 1,138 shares during the quarter. First Hawaiian Bank’s holdings in DaVita were worth […]
- 10/09/2020
|
Asia-Pacific Kidney Cancer Therapeutics & Diagnostics Market Symptoms, Transmission, Diagnosis, Treatment and Prevention 2020-2026
- Oct 07, 2020 (Market Insight Reports) --
Final Report will add the analysis of the impact of COVID-19 on this industry. MarketIntelligenceData has recently...
- 10/07/2020
|
Renal Dialysis Market to reach USD 31.71 billion by 2024, Asahi Kasei Corp. and B. Braun Melsungen AG emerge as Key Contributors to growth | Technavio
- The Global Renal Dialysis Market will grow by USD 31.71 bn during 2020-2024
- 10/06/2020
|
Warren Buffett’s Berkshire Hathaway Sold This Health-Care Stock
- Berkshire Hathaway sold $176 million of shares of health-care provider DaVita in a recent self-tender. Warren Buffett’s firm remains the largest shareholder, with a 31.7% stake.
- 09/27/2020
|
Private Advisor Group LLC Invests $136,000 in Davita Inc (NYSE:DVA)
- Private Advisor Group LLC acquired a new stake in Davita Inc (NYSE:DVA) in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 1,719 shares of the company’s stock, valued at approximately $136,000. Other institutional investors have also made changes to their positions in the company. […]
- 09/26/2020
|
The Best Warren Buffett Stocks To Consider In This Falling Market
- With the market selling off hard and both economic and political uncertainty on the rise, many investors yearn to turn to the most trusted and respected investors in history.
- 09/24/2020
|
Leanne M. Zumwalt Sells 3,772 Shares of Davita Inc (NYSE:DVA) Stock
- Davita Inc (NYSE:DVA) VP Leanne M. Zumwalt sold 3,772 shares of the business’s stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $88.03, for a total value of $332,049.16. Following the sale, the vice president now owns 51,049 shares of the company’s stock, valued at $4,493,843.47. The […]
- 09/23/2020
|
Davita (NYSE:DVA) Sets New 12-Month High at $92.28
- Davita Inc (NYSE:DVA) reached a new 52-week high on Wednesday . The stock traded as high as $92.28 and last traded at $92.09, with a volume of 17087 shares trading hands. The stock had previously closed at $89.84. A number of research firms recently commented on DVA. Raymond James reiterated a “hold” rating on shares […]
- 09/18/2020
|
Davita’s (DVA) “Hold” Rating Reiterated at Raymond James
- Raymond James reissued their hold rating on shares of Davita (NYSE:DVA) in a report issued on Tuesday, AnalystRatings.com reports. A number of other research analysts also recently issued reports on the company. Zacks Investment Research upgraded Davita from a hold rating to a buy rating and set a $100.00 price objective for the company in […]
- 09/18/2020
|
Librarian Capital Monthly Update - August 2020
- Our long-only portfolio gained 4.8% in GBP (7.1% in USD) in August, taking our year-to-date gain to 5.4%, ahead of MSCI World’s 4.7%.
- 09/15/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2020 Update
- Glenview Capital Management's 13F portfolio value decreased from $3.68B to $3.63B this quarter. The number of positions decreased from 44 to 43.
- 09/04/2020
|
Investors Purchase High Volume of Call Options on Davita (NYSE:DVA)
- Davita Inc (NYSE:DVA) was the recipient of some unusual options trading activity on Thursday. Investors acquired 7,814 call options on the company. This is an increase of 690% compared to the typical daily volume of 989 call options. A number of research firms have recently issued reports on DVA. SunTrust Banks lifted their price objective […]
- 08/28/2020
|
Buffett’s DaVita Stock Looks Like A Bull Trap
- Stocks Analysis by EWM Interactive covering: DaVita HealthCare Partners Inc, Berkshire Hathaway Inc. Read EWM Interactive 's latest article on Investing.com
- 08/25/2020
|
Davita Inc (NYSE:DVA) Shares Purchased by New Mexico Educational Retirement Board
- New Mexico Educational Retirement Board grew its stake in shares of Davita Inc (NYSE:DVA) by 5.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 5,986 shares of the company’s stock after buying an additional 300 shares during the period. New Mexico Educational Retirement Board’s […]
- 08/22/2020
|
DVA vs. CHE: Which Stock Is the Better Value Option?
- DVA vs. CHE: Which Stock Is the Better Value Option?
- 08/19/2020
|
Healthcare Dashboard For August
- A dashboard with metrics of value, quality and momentum by industries. Value and quality scores relative to historical averages.
- 08/18/2020
|
DaVita launches $1 billion stock buyback offer
- Shares of DaVita Inc. rallied 2.7% in premarket trading Monday, after the kidney services provider said it has launched a tender to buy back up $1 billion worth of its stock. The company said it will pay no less than $77 a share and not more than $88 a share for it stock, which closed Friday at $82.17. At Friday's closing price, a $1 billion buyback could represent about 12.2 million shares, or about 10% of the shares outstanding. DaVita said it expects to fund the share repurchases with cash on hand and if necessary, borrowing under its current undrawn $1 billion revolving line of credit. The stock has gained 9.5% year to date through Friday, while the S&P 500 has tacked on 4.4%.
- 08/17/2020
|
DaVita Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common Stock
- DaVita Inc. (NYSE: DVA) ("DaVita"), a health care provider focused on transforming care delivery to improve quality of life for patients globally and one of the largest providers of kidney care services in the United States, announced today that it has commenced a modified "Dutch auction" tender offer for shares of its common stock for an aggregate purchase price of up to $1.0 billion at a price per share of not less than $77.00 and not more than $88.00. The tender offer will expire at 12:00 midnight, New York City time, at the end of the day on September 14, 2020, unless extended by DaVita or otherwise terminated. Tenders of shares must be made on or prior to the expiration of the tender offer and may be withdrawn at any time prior to the expiration of the tender offer, in each case, in accordance with the procedures described in the tender offer materials.
- 08/17/2020
|
Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q2 2020 Update
|
The Zacks Analyst Blog Highlights: Best Buy, Activision Blizzard, DaVita, Micron and PulteGroup
- The Zacks Analyst Blog Highlights: Best Buy, Activision Blizzard, DaVita, Micron and PulteGroup
- 08/13/2020
|
DaVita Expands Initiative to Advance Nursing Education
- DaVita has expanded a tuition and support program for its clinical teammates to help them earn an associate's degree in nursing. The program, named Bridge to Your Dreams, includes comprehensive resources to help support and guide selected DaVita patient care technicians, licensed vocational nurses and licensed practical nurses currently employed with the company as they advance their education.
- 08/13/2020
|
DaVita Announces Paula A. Price to Join its Board of Directors
- DaVita Inc. (NYSE: DVA) announced today that its Board of Directors appointed a new independent director, Ms. Paula A. Price, to join the Board, effective September 1, 2020.
- 08/11/2020
|
Business is booming for dialysis giant Fresenius. It took a $137 million COVID-19 bailout anyway
- Funding to giant dialysis providers would have been greater if DaVita, the other multinational corporation that dominates dialysis care in the U.S., h...
- 08/11/2020
|
How Adam Smith Might Have Valued Amazon, Netflix, Tesla, And Tiny Biotechs (NASDAQ:AMZN)
- Adam Smith's invisible hand implies that the value a business provides to its customers is conjoined with the value of a business to its self-interested owners.
- 08/10/2020
|
Business Is Booming for Dialysis Giant Fresenius. It Took a $137M Bailout Anyway.
- Half of the money the Trump administration gave dialysis companies was collected by Fresenius, an international juggernaut with a robust balance sheet, a KHN analysis has found.
- 08/10/2020
|
Davita (NYSE:DVA) Upgraded at Zacks Investment Research
- Zacks Investment Research upgraded shares of Davita (NYSE:DVA) from a hold rating to a buy rating in a report released on Monday, Zacks.com reports. They currently have $100.00 price objective on the stock. According to Zacks, “DaVita ended the second quarter on a mixed note as earnings beat but revenues missed estimates. The significant improvement […]
- 08/09/2020
|
DaVita Inc. Announces Pricing of $1.5 Billion Senior Notes Offering
- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes"). The 2031 notes were priced at 100% of their face amount to yield a 3.750% coupon. The offering is expected to close on August 11, 2020, subject to satisfaction of customary closing conditions.
- 08/06/2020
|
The Zacks Analyst Blog Highlights: DaVita, PayPal, Century Communities, Berry Global and Turning Point Brands
- The Zacks Analyst Blog Highlights: DaVita, PayPal, Century Communities, Berry Global and Turning Point Brands
- 08/06/2020
|
DaVita Inc. -- Moody's assigns Ba3 rating to DaVita's new unsecured notes
- Moody's Investors Service ("Moody's") announced today that it assigned a Ba3 rating to DaVita Inc.'s ("DaVita") proposed senior unsecured global notes due 2031. There is no change to DaVita's existing ratings, including its Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default Rating, Ba1 senior secured rating, and Ba3 unsecured rating.
- 08/06/2020
|
DaVita Inc. Announces Offering of $1.5 Billion Senior Notes
- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering of $1.5 billion aggregate principal amount of senior notes due 2031 (the "2031 notes"), subject to market and other conditions.
- 08/06/2020
|
Short Interest in Davita Inc (NYSE:DVA) Increases By 5.6%
- Davita Inc (NYSE:DVA) saw a significant growth in short interest in July. As of July 15th, there was short interest totalling 6,040,000 shares, a growth of 5.6% from the June 30th total of 5,720,000 shares. Approximately 5.0% of the company’s stock are short sold. Based on an average trading volume of 1,090,000 shares, the short-interest […]
- 08/05/2020
|
Buy These 5 Stocks Before It's Too Late
- Stocks Analysis by Zacks Investment Research covering: S&P 500, Microsoft Corporation, DaVita HealthCare Partners Inc, Packaging Corp of America. Read Zacks Investment Research's latest article on Investing.com
- 08/05/2020
|
Is DaVita HealthCare (DVA) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 08/04/2020
|
DVA vs. CHE: Which Stock Should Value Investors Buy Now?
- DVA vs. CHE: Which Stock Is the Better Value Option?
- 08/03/2020
|
DaVita HealthCare (DVA) Hits Fresh High: Is There Still Room to Run?
- DaVita HealthCare (DVA) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 08/03/2020
|
Davita Inc (NYSE:DVA) Position Trimmed by Sumitomo Mitsui Trust Holdings Inc.
- Sumitomo Mitsui Trust Holdings Inc. trimmed its holdings in shares of Davita Inc (NYSE:DVA) by 26.1% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 441,513 shares of the company’s stock after selling 155,677 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned about […]
- 08/03/2020
|
Critical Review: Davita (NYSE:DVA) and CRYO-CELL International (NYSE:CCEL)
- Davita (NYSE:DVA) and CRYO-CELL International (OTCMKTS:CCEL) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, earnings, dividends, profitability, valuation and risk. Earnings & Valuation This table compares Davita and CRYO-CELL International’s top-line revenue, earnings per share and valuation. […]
- 08/02/2020
|
Davita Inc (NYSE:DVA) Shares Bought by Nisa Investment Advisors LLC
- Nisa Investment Advisors LLC grew its position in Davita Inc (NYSE:DVA) by 27.9% in the second quarter, HoldingsChannel reports. The fund owned 35,778 shares of the company’s stock after acquiring an additional 7,799 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Davita were worth $2,831,000 at the end of the most recent reporting […]
- 08/01/2020
|
DaVita (DVA) Earnings Beat Estimates in Q2, Revenues Miss
- DaVita's (DVA) dialysis services in the United States were solid in Q2.
- 07/31/2020
|
Column: California's ballot measures will produce a deluge of special-interest cash
- Get ready for a torrent of special-interest spending on California ballot measures.
- 07/31/2020
|
DaVita HealthCare Partners Inc (DVA) Q2 2020 Earnings Call Transcript
- DVA earnings call for the period ending June 30, 2020.
- 07/31/2020
|
DaVita Inc. (DVA) CEO Javier Rodriguez on Q2 2020 Results - Earnings Call Transcript
- DaVita Inc. (NYSE:DVA) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants Jim Gustafson - Vice President of Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Pito Chickering - Deutsche Bank Kevin Fischbeck - Bank of America Andrew Mok - Barclays Justin Lake - Wolfe Research Whit Mayo - UBS Gary Taylor - JPMorgan Matt Larew - William Blair Presentation Operator Good evening.
- 07/30/2020
|
DaVita HealthCare (DVA) Beats Q2 Earnings Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of 51.16% and -1.13%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/30/2020
|
Where to invest $10,000 right now? | AlphaStreet
- If you want to invest in stocks right now, it will be prudent to take a look at Warren Buffett's holdings. Warren Buffett has been one of the ...
- 07/28/2020
|
Dilution Could Cause Pop To Fizzle At TCR2 Therapeutics
- TCR2 announced interesting preliminary results from a Phase 1 trial. The stock is up in pre-market trading.
- 07/27/2020
|
DaVita (DVA) to Report Q2 Earnings: What's in the Offing?
- Solid performance within net dialysis and related lab patient service segment is likely to have contributed to DaVita's (DVA) top line in Q2.
- 07/27/2020
|
DaVita HealthCare (DVA) Earnings Expected to Grow: Should You Buy?
- DaVita HealthCare (DVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/23/2020
|
Healthcare Dashboard For July
- A dashboard with metrics of value, quality and momentum by industries. Value and quality scores relative to historical averages.
- 07/21/2020
|
DaVita Inc. (NYSE:DVA) Screens Well But There Might Be A Catch
- When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 17x, you may...
- 07/16/2020
|
DaVita Inc. Schedules 2nd Quarter 2020 Investor Conference Call
- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, July 30, 2020, at 5:00 p.m. Eastern Time. The company plans to release its results after market close the same day.
- 07/15/2020
|
Berkshire Is Not Bearish On DaVita, And You Should Not Be Either
- The recent sale of DaVita stock by Berkshire Hathaway is not indicative of either Warren Buffett or Ted Weschler souring on the stock.
- 07/14/2020
|
3 Growth-Focused MedTech Stocks to Buy Amid Coronavirus Crisis
- Once the pandemic-led crisis is over, these MedTech growth-focused stocks will flourish on a number of positive developments.
- 07/10/2020
|
Top Ranked Growth Stocks to Buy for July 9th
- Top Ranked Growth Stocks to Buy for July 9th
- 07/09/2020
|
DVA or CHE: Which Is the Better Value Stock Right Now?
- DVA vs. CHE: Which Stock Is the Better Value Option?
- 07/08/2020
|
Is DaVita (DVA) Outperforming Other Medical Stocks This Year?
- Is (DVA) Outperforming Other Medical Stocks This Year?
- 07/07/2020
|
Were Hedge Funds Right About DaVita Inc (DVA)?
- At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]
- 07/07/2020
|
HighTower Advisors LLC Sells 32,207 Shares of Davita Inc (NYSE:DVA)
- HighTower Advisors LLC lessened its holdings in shares of Davita Inc (NYSE:DVA) by 81.0% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,557 shares of the company’s stock after selling 32,207 shares during the quarter. HighTower Advisors LLC’s holdings in Davita were worth $576,000 […]
- 07/05/2020
|
Here's Why You Should Retain DaVita in Your Portfolio Now
- Investor confidence is high on DaVita (DVA), thanks to solid prospects.
- 07/03/2020
|
New Post From Your Neighbor
- Here's the latest article in the Sun: https://bit.ly/2YPF18W...
- 07/01/2020
|
New Post From Your Neighbor
- FDA WARNING: These 9 hand sanitizers can be toxic; stop use...
- 07/01/2020
|
Patient with kidney disease feels hopeful at home during COVID-19 pandemic
- (BPT) - For the last three years, Terry McCallum, 75, has been receiving dialysis treatments from the comfort of his home. When he initially considered the change from in-center hemodialysis (ICHD) to peritoneal dialysis (PD), it was because he was having a hard time adjusting to dialysis and experiencing low blood sugar. Now, amid a pandemic, his choice to treat at home has provided an unexpected benefit: the ability to shelter in place while managing his kidney disease.
The COVID-19 pandemic has swept through the country, forcing many Americans to take shelter within their homes. For several weeks, most states issued "stay at home" orders. Now, communities are beginning to reopen, but many local officials have continued to require social distancing and the use of masks in public spaces as a precaution to keep the virus from spreading.
For at-risk populations, such as those with kidney failure, continuing to limit exposure to the virus is essential. In fact, many health care professionals have petitioned at-risk patients to stay home, when possible.
"Being a PD patient is wonderful because I don't have to travel outside of my home for treatment," says McCallum, who receives dialysis through DaVita Kidney Care .
Though many patients with kidney failure choose to treat in dialysis centers where care team members are responsible for all aspects of patient care, some patients such as McCallum choose to take responsibility for their care at home. McCallum can connect remotely with his nephrologist and care team for support and check-ins at home, while he and his wife actively administer his PD treatments. He is comfortable with the trade-off because of the flexibility PD provides for his work and family life.
In...
- 06/25/2020
|
New Post From Your Neighbor
- Why isn't DCS taking care of their employees?
- 06/25/2020
|
Dialysis Market to touch USD 177.56 Billion by 2027; Increasing Number of Renal Therapy Clinics Worldwide to Positively Impact the Market: Fortune Business Insights™
- The global dialysis market size is projected to reach USD 177.56 billion by 2027, exhibiting a CAGR of 7.7% during the forecast period. Complications caused in
- 06/25/2020
|
Sevan modernisiert 21.000. Verkaufsraum
- Sevan Multi-Site Solutions, Inc. (Sevan), ein weltweit führendes Unternehmen für innovatives Design, Programmmanagement, Baudienstleistungen und Daten
- 06/25/2020
|
New Post From Your Neighbor
- Desert Dog Offroad & Outdoor, plenty of ammo and firearms...
- 06/24/2020
|
New Post From Your Neighbor
- United Food Bank Weekly Food Distribution at...
- 06/24/2020
|
New Post From Your Neighbor
- Boost Your Immune System While Helping Feed the Hungry...
- 06/24/2020
|
Sevan Refreshes 21,000th Retail Space
- Sevan Multi-Site Solutions, Inc. (Sevan) reached a major milestone and completed refreshing their 21,000th retail space.
- 06/24/2020
|
New Post From Your Neighbor
- Hello President Trump. Let's hear it for us poor Seniors...
- 06/23/2020
|
DaVita Inc. -- Moody's announces completion of a periodic review of ratings of DaVita Inc.
- Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of DaVita Inc. New York, June 23, 2020 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of DaVita Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.
- 06/23/2020
|
New Post From Your Neighbor
- HOME SWEET HOME Residential Cleaning Services...
- 06/23/2020
|
Somatus Raises $64M Series C To Accelerate Kidney Disease Diagnosis
- Somatus’ proprietary model uses actionable intelligence to provide personalized care plans aimed at achieving better kidney health.
- 06/23/2020
|
Alliancebernstein L.P. Raises Stock Position in Davita Inc (NYSE:DVA)
- Alliancebernstein L.P. increased its stake in Davita Inc (NYSE:DVA) by 2.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 167,833 shares of the company’s stock after purchasing an additional 3,246 shares during the quarter. Alliancebernstein L.P. owned 0.14% of Davita worth $12,765,000 at the […]
- 06/19/2020
|
Sevan Ranked Among Top Firms on Engineering News-Record’s 2020 Awards Lists
- Sevan Multi-Site Solutions ranked among top firms on Engineering News-Record’s 2020 Awards Lists
- 06/19/2020
|
Gilead Sciences : Javier Rodriguez Joins Gilead Sciences Board of Directors | MarketScreener
|
DaVita Kidney Care Appoints Chief Nursing Officer
- DaVita Kidney Care recently announced Mandy Hale as the company's chief nursing officer. Hale most recently served as the company's vice president of nursing, overseeing more than 18,000 nurses and 19,000 patient care technicians.
- 06/17/2020
|
APG Asset Management N.V. Sells 84,480 Shares of Davita Inc (NYSE:DVA)
- APG Asset Management N.V. trimmed its stake in shares of Davita Inc (NYSE:DVA) by 62.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 49,808 shares of the company’s stock after selling 84,480 shares during the quarter. APG Asset Management N.V.’s holdings […]
- 06/17/2020
|
Gilead Sciences : Javier Rodriguez Joins Gilead Sciences' Board of Directors | MarketScreener
|
Investing Lessons From Arnold Van Den Berg
- Three investing lessons I've learned from Arnold Van Den Berg Continue reading...
- 06/16/2020
|
Javier Rodriguez Joins Gilead Sciences’ Board of Directors
- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Javier Rodriguez has been appointed to the company’s Board of Directors. Mr. Rodriguez is th
- 06/16/2020
|
At A Time Of Great Need, Public Health Lacks ‘Lobbying Muscle’
- Public health officials are asking for more money in California’s state budget. But unlike some rich and powerful health care interests, they don’t have an army of lobbyists to curry favor with law…
- 06/15/2020
|
The Top Stocks To Buy On A Crash
- Growing volatility creates opportunities in the best stocks and sectors. Healthcare and technology remain top sectors to buy. Here are the best stocks to buy in
- 06/12/2020
|
Here's Why You Should Retain VEEVA Systems (VEEV) Stock Now
- Investor confidence is high in VEEVA Systems (VEEV), thanks to solid prospects.
- 06/11/2020
|
DVA vs. CHE: Which Stock Is the Better Value Option?
- DVA vs. CHE: Which Stock Is the Better Value Option?
- 06/10/2020
|
Has DaVita (DVA) Outpaced Other Medical Stocks This Year?
- Is (DVA) Outperforming Other Medical Stocks This Year?
- 06/10/2020
|
Surmodics Gets CE Mark for SurVeil Drug-Coated Balloon
- Surmodics' (SRDX) receipt of CE Mark for SurVeil DCB should boost the company's Medical Devices segment.
- 06/10/2020
|
DexCom's (DXCM) G6 CGM System Gets CE Marking in Europe
- DexCom (DXCM) announces the receipt of CE Marking across Europe for its G6 CGM System.
- 06/10/2020
|
$2.91 Billion in Sales Expected for Davita Inc (NYSE:DVA) This Quarter
- Brokerages expect Davita Inc (NYSE:DVA) to announce $2.91 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Six analysts have issued estimates for Davita’s earnings, with estimates ranging from $2.88 billion to $2.96 billion. Davita reported sales of $2.84 billion in the same quarter last year, which indicates a positive year […]
- 06/10/2020
|
DaVita: Built To Thrive In These Difficult Times (NYSE:DVA)
- DaVita is one of the largest providers of dialysis in the nation. The company's chief product, dialysis, is largely recession proof. Management has made wise fi
- 06/09/2020
|
Global Renal Dialysis Market (2020 to 2024) - Featuring DaVita, Diaverum and Medtronic Among Others - ResearchAndMarkets.com
|
Expert Series: Flattening the Curve: A Nurse’s Petition to Practice Social Distancing
- (BPT) - By Mandy Hale, DNP, MSN, MBA, RN, CNN, chief nursing officer for DaVita Kidney Care
In almost 20 years as a caregiver in the field of dialysis, I have seen the rise of infectious diseases, but the COVID-19 pandemic has brought with it new procedures and unfamiliar hazards. Because the virus is spread through prolonged, close contact (less than six feet apart), we've been told that hallmarks of social life like sporting events, birthday parties and even simply hanging out with friends are no longer safe. From this, we've learned of a new phrase, "social distancing," which has found footing in our everyday vocabulary and even inspired memes. But what is social distancing and how can it protect individuals and those most vulnerable to the virus?
According to the Centers for Disease Control and Prevention (CDC), "Social distancing is one of the best tools we have to avoid being exposed to this virus and slowing its spread locally and across the country and world. " 1 As each U.S. state eases Stay-at-Home restrictions, maintaining at least a six-foot distance between ourselves and others is an effective way for communities to protect each other and those who are immunocompromised.
I've spent the majority of my career caring for patients with kidney disease in several different capacities, first as a patient care technician, a registered nurse providing direct patient care, and currently as vice president of nursing for DaVita. There are over 37 million patients with kidney disease in the U.S. In the days to come, we can help these patients stay healthy and away from hazards in the hospital by following the CDC guidelines on social distancing . 2 We...
- 06/05/2020
|
Global Ambulatory Healthcare Services Market (2019 to 2027) - Impact of COVID-19 - ResearchAndMarkets.com
|
DaVita Sets Up Classic Pattern
- Keep your eyes open for new setups as the pullback could be temporary. DaVita setting up a cup with handle with 85.42 buy point. RS line lagging but if money rotates here it could be actionable.
- 06/04/2020
|
Edited Transcript of DVA earnings conference call or presentation 5-May-20 9:00pm GMT
- Q1 2020 DaVita Inc Earnings Call
- 06/03/2020
|
China to cut clean coal from green bond eligibility list
- Major development with potential big flow-on impact on financing for investments, says CBI chief #china #climatebondsinitiative #greenprojectscatalogue
- 06/02/2020
|
Why One CEO Decided to Return $250 Million in Government Relief Funds
- “Our company is qualified for the funding… But philosophically, we don’t need the money to stay open.”
- 06/01/2020
|
Tracking Larry Robbins' Glenview Capital Management Portfolio - Q1 2020 Update
- Glenview Capital Management’s 13F portfolio value decreased around two-thirds from $11.42B to $3.68B this quarter. The number of positions decreased from 50 to
- 06/01/2020
|
Hedge Funds Have Never Been This Bullish On DaVita Inc (DVA)
- We at Insider Monkey have gone over 821 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of March 31st, near the height of the coronavirus market crash. In this article, we look at what those funds think […]
- 05/29/2020
|
Warren Buffett's Top 20 Highest Conviction Stock Picks
- See Warren Buffett's top 20 stocks analyzed in detail. Download a free spreadsheet with metrics that matter of all of Buffett's stock holdings.
- 05/29/2020
|
Does DaVita’s (DVA) Stock Buyback Strategy Make Sense in This Market?
- First Eagle Investment Management recently released its Q1 2020 Investor Letter, a copy of which you can download below. The First Eagle Fund of America posted a return of -23.72% for the quarter (without sales charge), underperforming its benchmark, the S&P; 500 Index which returned -19.60% in the same quarter. You should check out First […]
- 05/29/2020
|
Nephrology Practice Solutions Names New Chief Medical Officer
- Nephrology Practice Solutions (NPS) today announced that Dr. Thao Truong Pascual has assumed the role of chief medical officer (CMO). As a subsidiary of DaVita, NPS owns or manages nephrology practices throughout the U.S. that manage care for patients with chronic kidney disease.
- 05/28/2020
|
Nephrology Practice Solutions Names New Chief Medical Officer
|
DaVita Inc. Announces Pricing of $1.75 Billion Senior Notes Offering
- DaVita Inc. (NYSE: DVA) ("DaVita") announced today the pricing of its previously announced private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the "2030 notes"). The 2030 notes were priced at 100% of their face amount to yield a 4.625% coupon. The offering is expected to close on June 9, 2020, subject to satisfaction of customary closing conditions.
- 05/26/2020
|
DaVita Inc. -- Moody's assigns Ba3 rating to DaVita's new senior unsecured notes
- Moody's Investors Service ("Moody's") announced today that it assigned a Ba3 rating to DaVita Inc.'s ("DaVita") proposed senior unsecured global notes due 2030. There is no change to DaVita's existing ratings, including its Ba2 Corporate Family Rating (CFR), Ba2-PD Probability of Default Rating, Ba1 senior secured rating, and Ba3 unsecured rating.
- 05/26/2020
|
5 Coronavirus-Proof PEG Picks Suitable for GARP Investors
- PEG-based investing can be more rewarding with the addition of a few other relevant parameters amid coronavirus-led market rattle.
- 05/26/2020
|
DaVita Inc. Announces Offering of $1.75 Billion Senior Notes
- DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering of $1.75 billion aggregate principal amount of senior notes due 2030 (the "2030 notes"), subject to market and other conditions.
- 05/26/2020
|
DaVita Inc. Announces Pricing of $–.75 Billion Senior Notes Offering
|
Is DaVita HealthCare (DVA) a Great Value Stock Right Now?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/25/2020
|
DVA or CHE: Which Is the Better Value Stock Right Now?
- DVA vs. CHE: Which Stock Is the Better Value Option?
- 05/25/2020
|
Is DaVita (DVA) Outperforming Other Medical Stocks This Year?
- Is (DVA) Outperforming Other Medical Stocks This Year?
- 05/25/2020
|
1 Thing Warren Buffett Didn't Do During the Market Crash That May Surprise You
- Warren Buffett fans are always eager to see which stocks Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) is buying and selling. On May 15, Berkshire released its latest 13F form, which shows the company's holdings as of the end of March 31 -- after the markets crashed. Like many investors, Berkshire was selling many of its stocks.
- 05/24/2020
|
Francis Chou Slims 4 Positions in the 1st Quarter
- Canadian guru releases portfolio. Sells include major Berkshire bank holding Bank of America. Continue reading...
- 05/22/2020
|
The Best Stocks To Buy Now
- Stock picking is becoming critical. Focus on healthcare and technology. Here are the top stocks to buy now.
- 05/22/2020
|
Francis Chou Slims 4 Positions in the –st Quarter
|
Here's Why Warren Buffett's Berkshire Hathaway Has Lagged the S&P 500 (and Why It Could Have Been Worse) | The Motley Fool
- The world's most legendary investor doesn't exactly heed one of the most embraced tenets of building a portfolio.
- 05/21/2020
|
Positive Earnings Report Bodes Well for Dialysis Provider - Schaeffer's Investment Research
- DaVita Inc (DVA) has been climbing on the charts for much of the year and is well above breakeven levels
- 05/20/2020
|
Analysis on Impact of Covid-19- Renal Dialysis Market 2020-2024 | Increasing Number of ESRD Patients to Boost Growth | Technavio
- The renal dialysis market is poised to grow by USD 31.71 bn during 2020-2024, according to Technavio
- 05/20/2020
|
TIKR: a lightweight, cost-effective financial data terminal
- TIKR is a startup whose goal is to bring institutional-quality investment research tools to a broader audience. TIKR provides: Standardized financial data (from S&P Capital IQ) so that you can…
- 05/17/2020
|
The DaVita (NYSE:DVA) Share Price Is Up 61% And Shareholders Are Holding On
- Passive investing in index funds can generate returns that roughly match the overall market. But investors can boost...
- 05/16/2020
|
Summit Trail Advisors, LLC Buys Vanguard S&P 5……, Expeditors International of ...
|
Be the change: Registered nurse rejoins frontline caregivers in the fight against COVID-19
- (BPT) - It's early afternoon on a Thursday when Donna Portscher walks through the doors at a DaVita dialysis center in north Georgia. It is a familiar setting — the
- 05/14/2020
|
Bogle Investment Management L P Buys The Scotts Miracle Gro Co, DaVita Inc, Synaptics Inc, ...
|
NASDAQ Winning Streak Reaches Six Days as Tech Keeps Rising
- Stocks Analysis by Zacks Investment Research covering: Microsoft Corporation, General Mills Inc, Kimberly-Clark Corporation, SPDR S&P 500. Read Zacks Investment Research's latest article on Investing.com
- 05/12/2020
|
The All-Important Question Buffett Will Answer This Week
- For Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) shareholders and fans of Warren Buffett, the previous weekend was the most-anticipated event of the year. On Saturday, May 2, Buffett held his company's annual shareholder meeting (albeit virtually) and provided the usual dose of long-term wisdom that investors look for.
- 05/11/2020
|
Bright Horizons Family Solutions, Inc. (BFAM) CEO Stephen Kramer on Q1 2020 Results - Earnings Call Transcript
- Bright Horizons Family Solutions, Inc. (NYSE:BFAM) Q1 2020 Earnings Conference Call May 06, 2020, 17:00 ET Company Participants Michael Flanagan - Senior Direct
- 05/10/2020
|
Is DaVita a Buy?
- Dialysis is the process of using a medical circulation device (either at home or at a clinic) to substitute kidney functions for patients with end-stage kidney failure. Each year, over 100,000 Americans with new cases of renal failure visit dialysis clinics to receive appropriate treatment. Since the full cost of dialysis treatments is reimbursed by the U.S. government, a wave of providers has moved to capitalize on the opportunity.
- 05/08/2020
|
Should Value Investors Buy DaVita HealthCare (DVA) Stock?
- Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
- 05/07/2020
|
Is DaVita (DVA) Outperforming Other Medical Stocks This Year?
- Is (DVA) Outperforming Other Medical Stocks This Year?
- 05/07/2020
|
DaVita Continues to Support Teammates during COVID-19 Crisis
- DaVita Kidney Care recently announced its continued support for U.S. employees, known as teammates, during the COVID-19 pandemic by implementing and strengthening programs specifically created to meet the emerging needs of teammates based on their ongoing feedback.
- 05/07/2020
|
DaVita Continues to Support Teammates during COVID-–9 Crisis
|
The Dow’s 2-Day Winning Streak Is Over. So Why Is the Nasdaq Flying?
- It’s all about what’s inside each benchmarks
- 05/06/2020
|
DaVita shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.
|
SunTrust Robinson Humphrey Maintains Hold on DaVita, Raises Price Target of $90
|
DaVita (DVA) Q1 2020 Earnings Call Transcript
- Image source: The Motley Fool. DaVita (NYSE: DVA)Q1 2020 Earnings CallMay 05, 2020, 5:00 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorLadies and gentlemen, good evening.
- 05/06/2020
|
DaVita (DVA) Earnings and Revenues Beat Estimates in Q1
- DaVita's (DVA) dialysis services in the United States showcased solid results in Q1.
- 05/06/2020
|
Edited Transcript of DVA earnings conference call or presentation 5-May-20 9:00pm GMT
- Q1 2020 DaVita Inc Earnings Call
- 05/06/2020
|
DaVita (DVA) Earnings and Revenues Beat Estimates in Q1
|
DaVita HealthCare (DVA) Surpasses Q1 Earnings and Revenue Estimates
- DaVita HealthCare (DVA) delivered earnings and revenue surprises of 25.34% and 0.17%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 05/05/2020
|
DaVita Q1 Adj. EPS $1.830 Beats $1.470 Estimate, Sales $2.841B Beat $2.800B Estimate
|
DaVita Inc. COVID-19 Response Efforts and 1st Quarter 2020 Results
- During the first quarter of 2020, DaVita Inc. (NYSE: DVA) took significant steps to respond to the novel coronavirus (COVID-19) pandemic while continuing to provide high-quality care for its patients whose lives depend on receiving dialysis treatment multiple times each week.
- 05/05/2020
|
DaVita, Inc. to Host Earnings Call
- NEW YORK, NY / ACCESSWIRE / May 5, 2020 / DaVita, Inc. (NYSE:DVA) will be discussing their earnings results in their 2020 First Quarter Earnings call to be held on May 5, 2020 at 5:00 PM Eastern Time. ...
- 05/05/2020
|
DaVita Unveils DaVita Venture Group
|
DaVita Launches Venture Group to Accelerate Advancements in Kidney Care
- As part of its continued efforts to further transform patient care, DaVita today unveiled DaVita Venture Group (DVG). This group plans to accelerate DaVita's efforts to develop and deploy solutions that are designed to improve the health care and quality of life for people with kidney disease and related chronic conditions.
- 05/05/2020
|
Earnings Scheduled For May 5, 2020
|
DaVita Launches Venture Group to Accelerate Advancements in Kidney Care
|
DaVita Educates Patients to Help Keep Them Safe during COVID-19 Pandemic
- DaVita Kidney Care shares its COVID-19 patient education on DaVita.com/COVID. DaVita, known for delivering award-winning, multimedia kidney disease education, has invested in developing comprehensive COVID-19 education for dialysis patients, one of the most at-risk populations. During a time of uncertainty and change, these resources are empowering patients and helping to keep them safe.
- 05/04/2020
|
DaVita Educates Patients to Help Keep Them Safe during COVID-–9 Pandemic
|
3 Warren Buffett Stocks to Buy Right Now
- Below are three stocks Berkshire holds that can be great additions to your portfolio today. The company's coming off a strong 2019, in which its adjusted per-share profits were $5.40, well above the $3.57 it reported for the previous year. On DaVita's earnings call in February, CFO Joel Ackerman projected even more growth for 2020, expecting adjusted EPS to fall between $5.75 and $6.25.
- 05/03/2020
|
Exercise caution after April run-up: strategist | MarketScreener
|
DIARY-U.S. earnings week ahead
- Diary of U.S. (.SPX) corporate earnings for the week ahead.
** Please Note - All times given are in U.S. EDT unless otherwise stated **
U.S. EARNINGS
Start Date Start RIC Company Name Event Name
Time
04-May-2020 07:00 SRE Sempra Energy Q1 2020 Sempra Energy Earnings Release
04-May-2020 BMO TSN Tyson Foods Inc Q2 2020 Tyson Foods Inc Earnings Release
04-May-2020 BMO WAB Westinghouse Air Q1 2020 Westinghouse Air Brake Technologies
Brake Corp Earnings Release
Technologies
Corp
04-May-2020 BMO L Loews Corp Q1 2020 Loews Corp Earnings Release
04-May-2020 BMO PEG Public Service Q1 2020 Public Service Enterprise Group Inc
Enterprise Group Earnings Release
Inc
04-May-2020 BMO WEC WEC Energy Group Q1 2020 WEC Energy Group Inc Earnings Release
Inc
04-May-2020 AMC JKHY.O Jack Henry & Q3 2020 Jack Henry & Associates Inc Earnings
Associates Inc Release
04-May-2020 AMC WMB Williams Q1 2020 Williams Companies Inc Earnings Release
Companies Inc
04-May-2020 AMC VAR Varian Medical Q2 2020 Varian Medical Systems Inc Earnings
Systems Inc Release
04-May-2020 16:00 O Realty Income Q1 2020 Realty Income Corp Earnings Release
Corp
04-May-2020 AMC UNM Unum Group Q1 2020 Unum Group Earnings Release
04-May-2020 AMC MHK Mohawk Q1 2020 Mohawk Industries Inc Earnings Release
Industries Inc
04-May-2020 AMC AIG American Q1 2020 American International Group Inc
International Earnings Release
Group Inc
04-May-2020 AMC LEG Leggett & Platt Q1 2020 Leggett & Platt Inc Earnings Release
Inc
04-May-2020 AMC VNO Vornado Realty Q1 2020 Vornado Realty Trust Earnings Release
Trust
04-May-2020 AMC MOS Mosaic Co Q1 2020 Mosaic Co Earnings Release
04-May-2020 AMC SWKS.O Skyworks Q2 2020 Skyworks Solutions Inc Earnings Release
Solutions Inc
04-May-2020 AMC FANG.O Diamondback Q1 2020 Diamondback Energy Inc Earnings Release
Energy Inc
05-May-2020 06:55 XYL Xylem Inc Q1 2020 Xylem Inc Earnings Release
05-May-2020 07:00 INCY.O Incyte Corp Q1 2020 Incyte Corp Earnings Release
05-May-2020 08:00 ITW Illinois Tool Q1 2020 Illinois Tool Works Inc Earnings
Works Inc Release
05-May-2020 08:00 HWM Howmet Aerospace Q1 2020 Howmet Aerospace Inc Earnings Release
Inc
05-May-2020 BMO TT Trane Q1 2020 Trane Technologies PLC Earnings Release
Technologies PLC
05-May-2020 BMO EXPD.O Expeditors Q1 2020 Expeditors International of Washington
International of Inc Earnings Release
Washington Inc
05-May-2020 BMO TDG TransDigm Group Q2 2020 TransDigm Group Inc Earnings Release
Inc
05-May-2020 BMO REGN.O Regeneron Q1 2020 Regeneron Pharmaceuticals Inc Earnings
Pharmaceuticals Release
Inc
05-May-2020 BMO APTV Aptiv PLC Q1 2020 Aptiv PLC Earnings Release
05-May-2020 BMO MPC Marathon Q1 2020 Marathon Petroleum Corp Earnings
Petroleum Corp Release
05-May-2020 BMO ALK Alaska Air Group Q1 2020 Alaska Air Group Inc Earnings Release
Inc
05-May-2020 BMO SEE Sealed Air Corp Q1 2020 Sealed Air Corp Earnings Release
05-May-2020 BMO IPGP.O IPG Photonics Q1 2020 IPG Photonics Corp Earnings Release
Corp
05-May-2020 BMO HSIC.O Henry Schein Inc Q1 2020 Henry Schein Inc Earnings Release
05-May-2020 BMO SYY Sysco Corp Q3 2020 Sysco Corp Earnings Release
05-May-2020 BMO AOS A. O. Smith Corp Q1 2020 A. O. Smith Corp Earnings Release
05-May-2020 BMO D Dominion Energy Q1 2020 Dominion Energy Inc Earnings Release
Inc
05-May-2020 BMO MLM Martin Marietta Q1 2020 Martin Marietta Materials Inc Earnings
Materials Inc Release
05-May-2020 BMO DD Dupont De Q1 2020 Dupont De Nemours Inc Earnings Release
Nemours Inc
05-May-2020 BMO LDOS Leidos Holdings Q1 2020 Leidos Holdings Inc Earnings Release
Inc
05-May-2020 BMO AME AMETEK Inc Q1 2020 Ametek Inc Earnings Release
05-May-2020 BMO LHX L3Harris Q1 2020 L3Harris Technologies Inc Earnings
Technologies Inc Release
05-May-2020 BMO NEM Newmont Q1 2020 Newmont Goldcorp Corp Earnings Release
Corporation
05-May-2020 AMC FMC FMC Corp Q1 2020 FMC Corp Earnings Release
05-May-2020 AMC AIZ Assurant Inc Q1 2020 Assurant Inc Earnings Release
05-May-2020 AMC PEAK Healthpeak Q1 2020 Healthpeak Properties Inc Earnings
Properties Inc Release
05-May-2020 AMC EA.O Electronic Arts Q4 2020 Electronic Arts Inc Earnings Release
Inc
05-May-2020 AMC RSG Republic Q1 2020 Republic Services Inc Earnings Release
Services Inc
05-May-2020 AMC DVN Devon Energy Q1 2020 Devon Energy Corp Earnings Release
Corp
05-May-2020 AMC PRU Prudential Q1 2020 Prudential Financial Inc Earnings
Financial Inc Release
05-May-2020 AMC DVA DaVita Inc Q1 2020 DaVita Inc Earnings Release
05-May-2020 AMC PGR Progressive Corp Q1 2020 Progressive Corp Earnings Release
05-May-2020 AMC EQR Equity Q1 2020 Equity Residential Earnings Release
Residential
05-May-2020 AMC WU Western Union Co Q1 2020 Western Union Co Earnings Release
05-May-2020 AMC ALL Allstate Corp Q1 2020 Allstate Corp Earnings Release
05-May-2020 AMC SBAC.O SBA Q1 2020 SBA Communications Corp Earnings
Communications Release
Corp
05-May-2020 AMC ANET Arista Networks Q1 2020 Arista Networks Inc Earnings Release
Inc
05-May-2020 AMC PKI PerkinElmer Inc Q1 2020 PerkinElmer Inc Earnings Release
05-May-2020 AMC VRSK.O Verisk Analytics Q1 2020 Verisk Analytics Inc Earnings Release
Inc
05-May-2020 AMC KLAC.O KLA Corp Q3 2020 KLA Corp Earnings Release
05-May-2020 AMC OXY Occidental Q1 2020 Occidental Petroleum Corp Earnings
Petroleum Corp Release
05-May-2020 AMC ATVI.O Activision Q1 2020 Activision Blizzard Inc Earnings
Blizzard Inc Release
06-May-2020 NTS FTNT.O Fortinet Inc Q1 2020 Fortinet Inc Earnings Release
06-May-2020 07:00 DISCA. Discovery Inc Q1 2020 Discovery Inc Earnings Release
O
06-May-2020 BMO VMC Vulcan Materials Q1 2020 Vulcan Materials Co Earnings Release
Co
06-May-2020 BMO ALXN.O Alexion Q1 2020 Alexion Pharmaceuticals Inc Earnings
Pharmaceuticals Release
Inc
06-May-2020 BMO GPC Genuine Parts Co Q1 2020 Genuine Parts Co Earnings Release
06-May-2020 BMO BWA BorgWarner Inc Q1 2020 BorgWarner Inc Earnings Release
06-May-2020 BMO NI NiSource Inc Q1 2020 NiSource Inc Earnings Release
06-May-2020 BMO CDW.O CDW Corp Q1 2020 CDW Corp Earnings Release
06-May-2020 BMO GM General Motors Q1 2020 General Motors Co Earnings Release
Co
06-May-2020 BMO GPN Global Payments Q1 2020 Global Payments Inc Earnings Release
Inc
06-May-2020 BMO AEP American Q1 2020 American Electric Power Company Inc
Electric Power Earnings Release
Company Inc
06-May-2020 BMO ZTS Zoetis Inc Q1 2020 Zoetis Inc Earnings Release
06-May-2020 BMO WM Waste Management Q1 2020 Waste Management Inc Earnings Release
Inc
06-May-2020 08:30 FLIR.
- 05/01/2020
|
What's in the Cards for DaVita (DVA)This Earnings Season?
- DaVita (DVA) is expected to have gained from Kidney Care segment in Q1.
- 05/01/2020
|
What's in the Cards for DaVita (DVA)This Earnings Season?
- DaVita (DVA) is expected to have gained from Kidney Care segment in Q1.
- 05/01/2020
|
Edited Transcript of AMGN earnings conference call or presentation 30-Apr-20 9:30pm GMT
- Q1 2020 Amgen Inc Earnings Call
- 05/01/2020
|
Edited Transcript of BAX earnings conference call or presentation 30-Apr-20 12:30pm GMT
- Q1 2020 Baxter International Inc Earnings Call
- 04/30/2020
|
New Report Reveals DaVita Engaged In "Lobbying Scheme" To Target Legislation Threatening Billing Loophole
- "...we thought it would be important to shed light on the ridiculous abuse of the medical system that continues under a cloak of legitimate lobbying efforts."
- 04/30/2020
|
Robeco Institutional Asset Management B.V. ...
|
First Eagle Fund of America Comments on DaVita
- First Eagle Fund of America Comments on DaVita, Stocks: DVA, First Eagle Investment, release date:Apr 29, 2020
- 04/29/2020
|
First Eagle Fund of America's 1st-Quarter Commentary
- First Eagle Fund of America's 1st-Quarter Commentary, Stocks: PRGO,HALO,BE,DVA,NVT,WYND,WH,MPC,MLM,POST, First Eagle Investment, release date:Apr 29, 2020
- 04/29/2020
|
